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Executive summary 
 
Duchenne muscular dystrophy (DMD) is an inherited neuromuscular disorder that predominantly 
affects boys and men. There is no known cure, so current clinical efforts are focused on improving the 
health-related quality of life (QoL) of people with DMD. Of the validated methods for assessing QoL, 
patient-reported outcome measures (PROMs) are the most common. In a field of many options, the 
choice of which PROM to use should be based predominantly on their validity and reliability for the 
construct, population, and context of use of interest. In the current report we critically reviewed the 
content and structural validity of PROMs used to assess QoL in people with DMD, using robust, 
updated COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) 
guidelines.  
 
In this review, we defined QoL as a multidimensional construct involving physical, psychological, and 
social components. We conducted a systematic search of the published literature for self-reported, 
multi-item PROMs assessing at least one aspect of QoL in a sample of at least 75% boys and men with 
DMD. We further refined these results for studies with evidence of content and structural validity, 
including development studies. The resulting PROMs and related studies were systematically rated, in 
terms of methodological quality, and evidence for content and structural validity, as per the latest 
COSMIN procedures. 
 
From an initial 1,752 records, and 5 additional records identified through citation tracking, 60 
published primary research articles were identified that had used a PROM to assess at least one aspect 
of QoL in people with DMD, of which 5 articles presented evidence on content or structural validity. A 
further 36 articles were identified through Google Scholar searching and citation tracking presenting 
content validity information on the development of the PROMs, resulting in a final selection of 41 
articles for review. From the articles identified, 40 PROMs were extracted, of which 26 were taken 
forward for COSMIN assessment.  
 
The results of the assessment for content validity revealed a modal COSMIN quality rating of 
inadequate, primarily due to the PROM development study not being performed in a sample of 
patients representing the target population (of people with DMD). The second most common rating 
was one of doubtful, due to at least some unclear details/suspected problems within the qualitative 
methods used. Only the KIDSCREEN family of measures received an adequate rating for concept 
elicitation and PROM design. Only two published articles had independently assessed the content 
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validity of the QoL PROMs (LSIA, PedsQL 3.0 NMM) in samples of people with DMD, and both received 
ratings of doubtful due to at least some unclear details/suspected problems with the qualitative 
methods used. In terms of the evidence on content validity assessed, the KIDSCREEN measures and 
the LSIA were the only PROMs to receive satisfactory results for all three dimensions of content 
validity. These reflect relevance (whether items are relevant for the construct, target, population, and 
context of use of interest); comprehensiveness (the extent to which all key aspects of the construct of 
interest are covered); and comprehensibility (the understanding of items and response options by the 
population of interest).  
 
Two studies had investigated the structural validity of the included PROMs (PedsQL 4.0 GCS, PedsQL 
3.0 NMM) in people with DMD, of which one received a very good COSMIN quality rating for its 
methodological content. Nevertheless, an assessment of the evidence for structural validity revealed 
a rating of indeterminate for the PedsQL 4.0 GCS, as key details of the results from the Rasch model 
were not reported, and a rating of unsatisfactory for the PedsQL 3.0 NMM, due to psychometric 
criteria for good measurement properties not being met.     
 
The results of this review suggest that evidence on the content and structural validity of PROMs 
assessing QoL in people with DMD is sparse, and further research is needed. In the absence of further 
evidence, we recommend that the KIDSCREEN is used to assess QoL in children and adolescents with 
DMD. It is difficult to recommend an adult measure, as insufficiencies are evident in content and/or 
structural validity, but in terms of precedent, the PedsQL is widely used, which has a young adult and 
adult variant. Furthermore, these two PROMs can be used in cost effectiveness analyses via mapping 
algorithms. Limitations of this review include the potential harshness of the worst score counts 
COSMIN system of assessment of methodological quality; the restriction to two, albeit the most 
important, measurement properties; and the potential restrictive nature of the inclusion criteria, 
which could be broadened to consider related neuromuscular disorders or mixed samples, if deemed 
theoretically appropriate.   
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1 Introduction 
 
Duchenne muscular dystrophy (DMD) is an inherited neuromuscular disorder that predominantly 
affects boys and men. It has an estimated incidence of 1:3800 to 1:6300 in live births.1 The disease 
causes progressive muscle weakness due to an absence of the dystrophin protein, which functions to 
help keep muscle cells intact. Diagnostic symptoms and functional impairment are evident from as 
early as two years old and average life expectancy of people with DMD is approximately 25 years,2 
although increasingly people with DMD are surviving into their fourth and even fifth decades.3 The 
disease progresses through four recognised clinical stages characterised by increased muscle 
weakness, impaired ambulation and motor functioning, and cardiovascular and respiratory problems.4 
There is no known cure for the disease. Current clinical efforts are thus focused on improving the 
health-related quality of life (QoL) of people with DMD, and health interventions are necessarily 
evaluated for their cost effectiveness against this objective. 
 
In order to attempt to measure QoL in people with DMD a number of condition-specific and generic 
questionnaires are used. For NICE, the institution responsible for making decisions on the funding of 
NHS health interventions, there is a stated preference that health-related QoL data comes from the 
EQ-5D.5 The EQ-5D is a generic, preference-based measure of health-related QoL with 5 dimensions 
covering mobility, self-care, usual activities, pain/discomfort, and anxiety and depression. In the case 
of DMD, however, there are a number of concerns that measures like the EQ-5D are insufficient to 
adequately assess QoL in this population, based on the aspects of QoL that matter to people living 
with DMD.6 For example, DMD is recognised to have an impact on aspects of daily life, such as 
participation, friendships, independence and dignity which may not be fully captured by generic 
measures, such as the EQ-5D (or its equivalent for children, the EQ-5D-Y).  
 
In order to satisfy NICE requirements, in cases where the EQ-5D is considered insufficient as a measure 
of health-related QoL for a particular population, and thus other measures may be more appropriate, 
evidence must be provided. Such evidence largely centres on the demonstrable validity of a measure, 
including its content validity and/or psychometric performance in the population of interest. Where 
it can be evidenced that the EQ-5D is inappropriate as a measure of health-related QoL, alternative 
preference-based measures, with superior validity, can be used to generate utility values, including 
condition-specific preference-based measures.   
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Given that a number of generic and condition-specific questionnaires are available for use in 
attempting to assess QoL in people with DMD, evidence is desperately needed on the relative validity 
and psychometric performance of these instruments, when it comes to assessing QoL in DMD. While 
we are aware of a number of reviews exploring QoL and associated measures in DMD, with some 
providing very basic information on their psychometric properties,6,7 no reviews to date have 
appropriately evaluated the content validity of available measures when it comes to assessing QoL in 
DMD. This is a striking omission; content validity has been defined by the COnsensus-based Standards 
for the selection of health Measurement INstruments (COSMIN) group as the most important property 
of a patient reported outcome measure (PROM).8 Furthermore, prior reviews on QoL in 
neuromuscular disorders have either not referred to, or used an outdated version of, COSMIN 
guidance, which is considered a rigorous approach to the systematic assessment(s) of the validity and 
reliability of PROMs. Updated and expanded COSMIN guidance and documentation for the evaluation 
of PROMs was published earlier this year, and, as a consequence of its importance in determining 
measure selection, this included a dedicated manual on assessing the content validity of PROMs.9 
 
Content validity refers to the extent that the content of a PROM adequately reflects the target 
construct that is being measured.10 It can be meaningfully subdivided into the relevance, 
comprehensiveness, and comprehensibility of a PROM, for assessing the construct of interest in a 
target population and context.9 Here, relevance of a PROM refers to whether the items are relevant 
for the construct, target population, and context of use of interest; the response options and recall 
period of a PROM should also be appropriate and relevant. Comprehensiveness is used to describe 
the extent to which all key aspects of the construct of interest are covered in the PROM. Finally, 
comprehensibility pertains to understanding of the items and response options by the population of 
interest.9 
 
A thorough assessment of a PROM ?s content validity should crucially include studies presenting 
information on content validity in the population of interest, but also consider the initial PROM 
development paper(s) and the content of the PROM itself.9 Content validity should form the first step 
of the assessment of the validity of a PROM, as it is integral to that PROM ?s usefulness in doing the 
job it was designed to do, and influences all other measurement properties.11 For example, a 
psychometrically responsive and internally consistent instrument is of little use if it is not measuring 
what it is intended to measure in the first place. 
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According to COSMIN guidance, the second most important form of the validity assessment of a PROM 
is structural validity.11 Structural validity describes the extent that scores derived from a measure 
adequately reflect the dimensionality of the construct being measured.12 Quality of life is usually 
defined, and thus measured, as a multidimensional construct. Therefore, PROMs that feature multiple 
dimensions of quality of life should be dutifully assessed to check they accurately represent the 
multidimensional structure of quality of life in the population of interest. If PROMs are designed to 
target a single dimension of quality of life, assessments should be undertaken to empirically 
demonstrate their unidimensional nature in the target population. If such assessments are not 
undertaken, subsequent interpretation of the data (e.g. through generating dimensional scores) may 
be inaccurate. 
 
This systematic review has been designed to evaluate the content and structural of QoL measures 
used in people with DMD using updated COSMIN guidance.9,13 A similar approach has recently been 
undertaken and published by members of the COSMIN group when evaluating PROMs for physical 
functioning used in people with low back pain.11 It forms part of an ongoing project funded by 
Duchenne UK on producing a preference-based measure (PBM) for people with DMD as part of the 
Project HERCULES initiative. 
 
For the purposes of this review, we define QoL as a multidimensional construct involving physical (e.g., 
pain, fatigue), psychological (e.g., mood, self-efficacy), and social (e.g., participation, stigma) 
components, based on the Comprehensive Model of QoL in Muscular Dystrophy (CMQM).6 However, 
here we operationalise QoL as a subjective construct and do not include purely functional 
performance or assessment scales that may impact on QoL. In this review, we consider multi-item 
PROMs that assess at least one aspect of QoL in people with DMD. 
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2 Objectives 
 
x To identify PROMs that are used in people with DMD to measure QoL 
x To assess the content validity of PROMs that are used in people with DMD 
x To assess the structural validity of PROMs that are used in people with DMD 
x To synthesise the evidence and make a recommendation on the use of available PROMs to 
assess QoL in people with DMD 
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3 Methodology 
 
3.1 Protocol registration 
The protocol was registered with PROSPERO, an international database of prospectively registered 
systematic reviews in health and social care, welfare, public health, education, crime, justice and 
international development, where there is a health related outcome. The protocol is accessible at:    
https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=93062 
 
3.2 Search strategy and information sources 
3.2.1 Searches 
A ScHARR information specialist was consulted in developing the appropriate search strategy and was 
responsible for conducting the main database searches.  
 
Search terms in this review included:  
I) Duchenne muscular dystrophy (and derivatives); 
II) A robust search filter developed by the PROM Group at the University of Oxford to identify 
PROMs; 
III) Patient-reported outcome measures known to be used with people with DMD based on an 
earlier rapid review of the literature; and 
IV) A robust search filter by the COSMIN Group for identifying studies on measurement 
properties, as recommended by the COSMIN Group.14 
A two-stage search strategy was used, where in the first stage, the search terms (I) AND ((II) OR (III)) 
were combined to identify articles using PROMs to measure QoL in DMD. In the second stage, search 
terms (I) AND (III) AND (IV) were combined with the names of all PROMs identified in Stage one of the 
search to identify articles reporting on the measurement properties of these instruments in DMD. No 
restrictions on time or language were applied to the search strategy. The two-stage search strategy 
has the advantage of allowing us to identify which PROMs have been used in published, peer-reviewed 
articles on DMD, in the absence of any evidence of content or structural validity for their use in this 
population.    
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3.2.2 Electronic databases 
The electronic databases searched for the systematic review are outlined in Table 1. All databases 
were searched from inception.   
 
Table 1.  Electronic databases for the primary searches. 
Database Platform Span of search 
Date searched 
(Stage 1) 
Date searched 
(Stage 2) 
EMBASE Ovid SP From 1974 April 2018 September 2018 
MEDLINE Ovid SP From 1946 April 2018 September 2018 
CINAHL EBSCOhost From 1981 April 2018 September 2018 
PsycINFO Ovid SP From 1967 April 2018 September 2018 
Cochrane library Wiley From 1989 April 2018 September 2018 
 
3.2.3 Search strings 
3.2.3.1 Stage 1 search strategy: 
Database: Ovid MEDLINE 
Platform: Ovid SP 
 
Table 2.  MEDLINE search string. 
 
 Query Results 
#1 Muscular Dystrophy, Duchenne/  4700 
#2 duchenne*.mp. 11822 
#3 #1 or #2 11822 
#4 (HR-PRO or HRPRO or HtaRQL or HRQoL or QL or QoL).ti,ab. or quality of 
life.mp. or (health index* or health indices or health profile*).ti,ab. or health 
status.mp. or ((patient or self or child or parent or carer or proxy) adj 
(appraisal* or appraised or report or reported or reporting or rated or rating* 
or based or assessed or assessment*)).ti,ab. or ((disability or function or 
functional or functions or subjective or utility or utilities or wellbeing or well 
being) adj2 (index or indices or instrument or instruments or measure or 
measures or questionnaire* or profile or profiles or scale or scales or score or 
scores or status or survey or surveys)).ti,ab. 
649346 
#5 'Pediatric Quality of Life Inventory'.mp. ( 884 
#6 PedsQL.mp. 1094 
#7 (SF-36 or EQ-5D*).mp. 24322 
#8 "World Health Organization Quality of Life".mp. 1373 
#9 (KIDSCREEN or Pittsburgh Sleep Quality questionnaire or PSQI).mp. [mp=title, 
abstract, original title, name of substance word, subject heading word, floating 
sub-heading word, keyword heading word, protocol supplementary concept 
word, rare disease supplementary concept word, unique identifier, synonyms] 
2710 
#10 "Childrens Assessment of Participation and Enjoyment".mp.  96 
#11 (CAPE or "Child Health Questionnaire" or CHQ* or Health Utilities Index 
Questionnaire or HUI*).mp.11 
17397 
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#12 (Fatigue Severity Scale or FSS or "Hospital Anxiety and Depression Scale" or 
HADS or COPE Inventory or "Quality of Life in Neuromuscular Disease").mp. 
10638 
#13 (QoL-NMD DISABKIDS or "Depressionsiventar fur kinder und Jugendliche" or 
DIKJ or Beck Depression Inventory or BDI or CARE-NMD or State-Trait Anxiety 
Inventory or STAI or "Life Satisfaction Index for Adolescents" or LSI-A or Quality 
of Life Evaluation Scale or AUQUEI or Activity Limitations Questionnaire or 
ACTIVLIM).mp. 
17368 
#14 (sf12 or sf 12 or short form 12 or shortform 12 or sf twelve or sftwelve or 
shortform twelve or short form twelve).mp. 
4980 
#15 (sf36 or sf 36 or short form 36 or shortform 36 or sf thirtysix or sf thirty six or 
shortform thirtysix or shortform thirty six or short form thirtysix or short form 
thirty six).mp. 
23191 
#16 #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 80226 
#17 #4 or #16 685940 
#18 #3 and #17 523 
 
 
3.2.3.2 Stage 2 search strategy: 
Database: Ovid MEDLINE 
Platform: Ovid SP 
 
Table 3.  MEDLINE search string. 
 
 Query Results 
#1 Muscular Dystrophy, Duchenne 4638 
#2 duchenne*.mp. 11693 
#3 #1 or #2 11693 
#4 Autoquestionnaire Qualite de vie Enfant Image.mp. 18 
#5 (Behavior Assessment System for Children or BASC or Parent Form 50 or PF50 
or DUX-25 or EuroQoL 5-domain or Functional Independence Measure* or 
FIM).mp. 
4877 
#6 (WeeFIM or Life Satisfaction Index or LSI or LSIA or Neurological Disorders 
Quality of Life Questionnaire or NeuroQOL or pediatric NeuroQOL or Offer Self-
Image Questionnaire for Adolescents or OSIQ).mp. 
1602 
#7 (Pediatric Outcomes Data Collection Instrument or PODCI or Neuromuscular 
module or DMD module or Multidimensional Fatigue Scale or Generic Short-
Form or SF15).mp. 
411 
#8 (SDQ or 'Strips of Life with Emoticons Questionnaire' or SOLE or 'World Health 
Organisation Quality of Life Scale-Brief Version' or WHOQOL-BREF).mp. 
53728 
#9 ('Strength and Difficulties Questionnaire').mp. [mp=title, abstract, original title, 
name of substance word, subject heading word, floating sub-heading word, 
keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms] 
223 
#10 "Individualized Neuromuscular Quality of Life Questionnaire".mp. 9 
#11 (INQOL or Child Activity Limitations Interview or CALI or "Satisfaction with Life 
Scale" or SWLS).mp. 
1461 
#12 'Pediatric Quality of Life Inventory'.mp. 871 
#13 ("Pediatric Orthopedic Society of North America Pediatric Musculoskeletal 
Functional Health Questionnaire" or POSNA or Pittsburgh Sleep Quality 
Index).mp. 
3411 
#14 PedsQL.mp. 1078 
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#15 (SF-36 or EQ-5D*).mp. 23965 
#16 "World Health Organization Quality of Life".mp. 1349 
#17 (KIDSCREEN or Pittsburgh Sleep Quality questionnaire or PSQI).mp. [mp=title, 
abstract, original title, name of substance word, subject heading word, floating 
sub-heading word, keyword heading word, protocol supplementary concept 
word, rare disease supplementary concept word, unique identifier, synonyms] 
2640 
#18 "Childrens Assessment of Participation and Enjoyment".mp. 96 
#19 (CAPE or "Child Health Questionnaire" or CHQ* or Health Utilities Index 
Questionnaire or HUI*).mp. 
17206 
#20 (Fatigue Severity Scale or FSS or "Hospital Anxiety and Depression Scale" or 
HADS or COPE Inventory or "Quality of Life in Neuromuscular Disease").mp. 
10441 
#21 (QoL-NMD DISABKIDS or "Depressionsiventar fur kinder und Jugendliche" or 
DIKJ or Beck Depression Inventory or BDI or CARE-NMD or State-Trait Anxiety 
Inventory or STAI or "Life Satisfaction Index for Adolescents" or LSI-A or Quality 
of Life Evaluation Scale or AUQUEI or Activity Limitations Questionnaire or 
ACTIVLIM).mp. 
17136 
#22 (sf12 or sf 12 or short form 12 or shortform 12 or sf twelve or sftwelve or 
shortform twelve or short form twelve).mp. 
4886 
#23 (sf36 or sf 36 or short form 36 or shortform 36 or sf thirtysix or sf thirty six or 
shortform thirtysix or shortform thirty six or short form thirtysix or short form 
thirty six).mp. 
22934 
#24 #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 
or #17 or #18 or #19 or #20 or #21 or #22 or #23 
140059 
#25 #3 and #24 82 
 
Full copies of the search strategies for Stage 1 and Stage 2 can be found in Appendix A. 
 
3.2.4 Additional searches 
Following establishes procedures,11 we searched Google Scholar (last searched 30th January 2019) 
with the names of the PROMs identified in Stage 1 in order to identify potential development papers 
for the assessment of content validity. The first 100 hits on Google Scholar were screened for inclusion. 
Citation tracking, by screening of references and Google Scholar citations of included articles, was 
conducted on the full text articles meeting eligibility criteria at Stage 2 (last searched 6th February 
2019), as a supplementary measure to identify any additional studies not captured by the database 
searching.15  
 
3.3 Eligibility criteria 
The following selection criteria was applied to the search results at Stage 1 (identifying PROMs): 
x Published in English as a full-text original research article (i.e. not including abstracts, 
editorials, or reviews). 
 15 | P a g e  
 
x Used a self-reported, multi-item PROM to assess at least one aspect of QoL in boys and/or 
men diagnosed with DMD (assisted or proxy-reported versions of PROMs were considered for 
inclusion so long as a self-report version of that PROM exists). 
x At least 75% of the sample, on which data from the PROM is reported, was male diagnosed 
with DMD. 
Additional selection criteria were applied at Stage 2 (content and structural validity):  
x Described data on the content and/or structural validity of the PROMs identified in Stage 1 in 
boys and/or men diagnosed with DMD. 
x Development studies on the PROMs identified in Stage 1, to assist with the assessment of 
content validity, were included in any published form (i.e. journal article, book chapter, user 
manual).  
 
3.4 Selection process 
In order to apply the eligibility criteria for the selection of papers from search results, the following 
steps were performed: 
I) Inclusion criteria (Stage 1) were applied to the titles and abstracts of hits from the Stage 1 
searches (and any additional papers identified in the Stage 2 searches or through citation 
tracking) by two independent reviewers. Records were selected for full-text review if deemed 
relevant, potentially relevant, or if doubt existed. Any discrepancy was resolved by a third 
reviewer. 
II) Full-text articles identified in (I) were screened for selection using the Stage 1 inclusion criteria 
by two independent reviewers. Any disagreements were resolved by a third reviewer through 
discussion.  
III) The PROMs identified in the articles in (II) were reviewed to ensure they met the requisite 
inclusion criteria (i.e. assessing an aspect of QoL). If a validated English PROM was not 
available for review, the corresponding articles were excluded.     
IV) Full-text articles identified in (II) and (III) meeting the Stage 1 inclusion criteria AND identified 
as containing measurement properties using the COSMIN filter were screened for content and 
structural evidence using the Stage 2 inclusion criteria by two independent reviewers. Any 
disagreements were resolved by a third reviewer. 
V) In order to identify key development papers for the PROMs identified in (II) and (III), Google 
Scholar was searched with the names of the PROMs and the first 100 hits were screened for 
inclusion.  Results of the searches were screened for inclusion by two reviewers. 
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VI)  Finally, citation tracking of all eligible articles at Stage 2 was conducted by reviewing 
references and citations on Google Scholar for any articles not identified in the initial searches 
that may meet the eligibility criteria for Stage 1 and/or Stage 2.  Results of the searches were 
screened for inclusion by two reviewers. 
 
3.5 Data extraction and quality appraisal 
Data extraction was carried out by two reviewers using a pre-prepared data extraction sheet, with 
consensus on any ambiguities reached through discussion. The data extraction sheet was informed by 
the tools developed by COSMIN on reporting guidance: 
https://www.cosmin.nl/tools/guideline-conducting-systematic-review-outcome-measures/ 
 
The methodological quality of the PROM development papers, and studies on content and structural 
validity were assessed using up-to-date COSMIN standards via the new COSMIN risk of bias checklist.16 
Thirty-five items are used to assess the development studies, comprised of a separate rating of the 
quality of the concept elicitation process with patients (i.e. item generation for a new PROM), and a 
rating of the quality of the cognitive interview study (if present) evaluating comprehensiveness and 
comprehensibility of the PROM with patients.16 Thirty-eight items are used to assess studies on 
content validity, made of one set of items assessing studies with patients about relevance, 
comprehensiveness, and comprehensibility, and the other set assessing studies with professionals (if 
present) about relevance and comprehensiveness.16 A total rating for relevance, comprehensiveness, 
and comprehensibility of a PROM is determined separately. A separate rating is also determined for 
studies with patients or professionals. Finally, four items are used to assess the methodological quality 
of a structural validity study.16    
 
When rating the methodological quality of the studies, each COSMIN standard (or item) is ranked on 
a 4-ƉŽŝŶƚƐĐĂůĞ P “ǀĞƌǇŐŽŽĚ ? ? “ĂĚĞƋƵĂƚĞ ? ? “ĚŽƵďƚĨƵů ? ?ĂŶĚ “ŝŶĂĚĞƋƵĂƚĞ ? ?dŽƚĂůƌĂƚŝŶŐƐĂƌĞĚĞƚĞƌŵŝŶĞĚ
using the lowest rating for any item for that study (i.e. worst score counts).17 Studies were initially 
rated independently by two reviewers, and, in the case of divergence, consensus was reached in a 
subsequent face-to-face meeting.    
 
3.6 Evidence synthesis 
In order to synthesise and assess evidence on content validity, two reviewers independently rated the 
results of PROM development studies, content validity studies, and the content of the PROM itself on 
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10 COSMIN criteria, split into 5 on relevance, 1 on comprehensiveness, and 4 on comprehensibility.9 
Ratings for each source of evidence could either be positive (+), negative (AL), or indeterminate (?). 
Following this an overall judgment on the relevance, comprehensiveness, and comprehensibility of 
each PROM was made, which could be sufficient (+), insufficient (AL), or inconsistent (±). Evidence on 
structural validity was assessed against the updated COSMIN criteria for good measurement 
properties, using the same rating scale as above.13 Finally, the quality of the evidence was graded using 
a modified GRADE approach,18 ĂƐ ĞŝƚŚĞƌ  “ŚŝŐŚ ? ?  “ŵŽĚĞƌĂƚĞ ? ?  “ůŽǁ ? ? Žƌ  “ǀĞƌǇ ůŽǁ ? ? dŚĞ 'Z
approach takes into account the risk of bias of studies (or study quality); (in)consistency across studies; 
imprecision (based on sample sizes); and indirectness (of evidence).13  
 
For quality assurance purposes, the quality of this systematic review itself was appraised against a 
recently developed COSMIN checklist to assess the quality of systematic reviews of health-related 
PROMs.14   
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4 Results 
 
4.1 Identification of included studies 
From an initial 1,752 records identified through database searching at Stage 1 and 2, 1,536 were 
excluded at the title/abstract review stage, leaving 216 papers for full-text review. Of these 216 
papers, 87 were excluded as they were not full-text published research articles; 26 did not meet the 
required sample criteria of at least 75% of the sample being boys or men with DMD; 21 were judged 
not to be assessing QoL; 16 were not published in English; and finally 11 papers did not feature a multi-
item PROM. Accordingly, a total of 55 records from the initial searches met the eligibility criteria for 
Stage 1.  The PROMs extracted from these papers are summarised in Section 4.2 below. The observed 
ƉƌŽƉŽƌƚŝŽŶĂƚĞĂŐƌĞĞŵĞŶƚďĞƚǁĞĞŶƌĞǀŝĞǁĞƌƐǁĂƐ ? ? ? ?A?ĂƚƚŝƚůĞ ?ĂďƐƚƌĂĐƚ ?ǁŝƚŚŽŚĞŶ ?Ɛ ʃ = 0.51 or 
 “ŵŽĚĞƌĂƚĞĂŐƌĞĞŵĞŶƚ ?ĂŶĚŝƐƐŝŵŝůĂƌƚŽŽƚŚĞƌƉƵďůŝƐŚĞĚƌĞǀŝĞǁƐ ?19-20 At full-text review, the observed 
proportionate agreement was 93.5% with ŽŚĞŶ ?Ɛʃ A? ? ? ? ?Žƌ “ĂůŵŽƐƚƉĞƌĨĞĐƚĂŐƌĞĞŵĞŶƚ ? ? A further 
5 articles that met the eligibility criteria for Stage 1 were added as a result of citation tracking.   
 
Of the papers that initially met the review criteria at Stage 1, subsequent to a review of the PROM 
itself, 5 were excluded as not containing content assessing QoL; 4 were not taken forward as no 
free/review copy was available; 3 were excluded because no validated English copy of the PROM was 
available; and 1 was excluded as the particular variant of the PROM used (of a potential large item 
bank) was not clear. Of the resultant 47 records, 20 were identified by the COSMIN measurement 
properties filter14 as potentially containing measurement properties. Following review, 11 of these 
records were excluded for containing information on measurement properties other than content and 
structural validity; and 4 were excluded as not containing information on measurement properties. 
The remaining 5 papers featured evidence on content validity (n = 3, of which one was classified as a 
development paper) and structural validity (n = 2). Finally, 33 PROM development papers were 
identified through a review of Google Scholar search results and 3 PROM development papers were 
identified through citation tracking, resulting in a final selection of 41 papers that met the eligibility 
for Stage 2 (see Figure 1). 
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Figure 1.  Flow diagram of search strategy and selection of papers.  
 
 
Records identified through database 
searching 
(n = 2392) 
Stage 1 (n = 2261) 
Stage 2 (n = 131) 
Records excluded title/abstract 
(n = 1536) 
Full-text articles assessed for 
eligibility 
(n = 216) 
Full-text articles excluded: 
Not English (n = 16) 
Not full research article (n = 87) 
Did not assess QoL (n = 21) 
Did not use multi-item PROM (n = 11) 
Inappropriate sample (n = 26)    
Full-text meeting eligibility criteria 
(Stage 1) 
(n = 60) 
Google Scholar searches 
(n = 33)  
Citation tracking 
(n = 3) 
Full-text meeting eligibility criteria 
(Stage 2) 
(n = 41) 
Development papers (n = 37) 
Content validity studies (n = 2) 
Structural validity studies (n = 2) 
Records after duplicates removed 
Screened at title/abstract 
(n = 1752) 
Full-text articles excluded: 
Other measurement properties (n = 11) 
No measurement properties (n = 4)    
Excluded based on PROM review: 
Content not quality of life (n = 5) 
No free/review copy available (n = 4) 
No validated English copy (n = 3)  
Unclear which PROM used (n = 1)   
Papers filtered for measurement 
properties (Terwee filter)14  
(n = 20) 
Citation tracking 
(n = 5) 
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4.2 PROMs used to measure quality of life in DMD 
Table 4 summarises the PROMs used to assess QoL in DMD from the full-texts meeting the initial 
eligibility criteria at Stage 1 (n = 60).  
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Table 4.  PROMs assessing QoL identified in published articles (n = 60) including samples of people with DMD. 
PROM Respondent type Recall Period N dimensions 
(items) 
Dimensions of quality of life 
assessed 
Response options Total score 
range 
Origin Validated English 
copy and 
development 
papers freely 
available for 
review? 
36-item Short-Form 
Health Survey (SF-
36) v1.021-28 
Adult self-report  Varies by dimension 8 + a single item of 
perceived change 
in health (36 items) 
Physical functioning; bodily pain; role 
limitations due to physical health 
problems; role limitations due to 
personal or emotional problems; 
emotional well-being; social 
functioning; energy/fatigue; general 
health perceptions  
Varies by dimension No total score 
calculated  
USA Yes 
SF-36 Health 
Survey v2.029 
Adult self-report  Varies by dimension 8 + a single item of 
perceived change 
in health (36 items) 
Assumed same as SF-36 v1.0 Varies by dimension No total score 
calculated  
USA No 
Autoquestionnaire 
Qualité de vie 
Enfant Imagé 
(AUQEI)30 
Child self-report  Unknown/undefined 4 + a total score (26 
items) 
Autonomy; leisure; functioning; 
family; total 
0 - 3 rating scale 
(with pictures) 
0  W 78 (raw) France  No 
Beck Depression 
Inventory I (BDI)25 
Adult interview 
or self-report 
Present/today 1 total score (21 
items) 
Depression 0 - 3 rating scale 0  W 63 (raw) USA Yes 
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Behavior 
Assessment System 
for Children (BASC) 
first edition31 
Child self-report 
Parent report 
Teacher report 
Unknown 
(withdrawn from 
use, superseded by 
BASC-II and BASC-III) 
Unknown 
(withdrawn from 
use, superseded by 
BASC-II and BASC-
III) 
Unknown (withdrawn from use, 
superseded by BASC-II and BASC-III) 
Unknown 
(withdrawn from 
use, superseded by 
BASC-II and BASC-III) 
Unknown 
(withdrawn 
from use, 
superseded by 
BASC-II and 
BASC-III) 
USA No 
Child Activity 
Limitations 
Interview (CALI)31  
Child interview or 
self-report 
Last 4 weeks 1 total score (8 
items chosen from 
a set of 21) 
Activity limitations 0 - 4 rating scale 0  W 32 (raw) USA Yes 
Child Health 
Questionnaire - 
Parent Form 50 
(CHQ-PF50)32-33 
Parent self-report Last 4 weeks (past 
year for change in 
health) 
14 (50 items) Physical functioning; role/social 
limitations  W physical; role/social 
limitations  W emotional; role/social 
limitations  W behavioral; general 
health perceptions; bodily 
pain/discomfort; family activities; 
parent impact  W time; parent impact 
 W emotion; self-esteem; mental 
health; behaviour; family cohesion; 
change in health   
Varies by dimension No total score 
calculated  
USA No 
ŚŝůĚƌĞŶ ?Ɛ
Assessment of 
Participation and 
Enjoyment 
(CAPE)34-36 
Child and young 
adults self-report 
or interview 
Unknown/undefined 5 + a total score (55 
items) 
Diversity of activities; intensity of 
activities (frequency of 
participation); enjoyment of 
activities; with whom; where; total 
participation  
Varies by dimension 0  W 55 (raw) USA No 
Depressions-
Inventar für Kinder 
und Jugendliche 
(DIKJ) 2nd edition25 
Child self-report Unknown/undefined 1 total score (26 
items) 
Depression Unknown/undefined 0  W 46 (raw) Germany No 
 23 | P a g e  
 
DISABKIDS generic 
module (DCGM-
37)25 
Child self-report 
Proxy report 
Past 4 weeks 6 + a total score (37 
items) 
Independence; emotion; social 
inclusion; social exclusion; limitation; 
treatment; total 
1  W 4 rating scale 37  W 148 (raw) Multi-country Yes 
DISABKIDS  W 
Smileys25 
Child self-report 
Proxy report 
Assumed same as 
DCGM-37 
Assumed same as 
DCGM-37 (12 
items) 
Assumed same as DCGM-37 Assumed same as 
DCGM-37 (with 
pictures) 
12  W 48 (raw) Multi-country No 
Dutch Children 
AZL/TNO 
Questionnaire 
Quality of Life Short 
Form (DUC-25)36 
Child self-report Unknown/undefined 4 + a total score 
(25 items) 
Physical; emotional; social; home 
functioning; total  
0 - 4 rating scale 0  W 100 (raw) Netherlands No 
EuroQoL 5-domain 
3-Level (EQ-5D-
3L)37-38 
Adult self-report 
Proxy report  
Present/today 5 (5 items) + self-
rated health VAS 
Mobility; self-care; usual activities; 
pain/discomfort; anxiety/depression 
1  W 3 rating scale AL0.594  W 1 
(utility scores) 
Multi-country Yes 
Fatigue Severity 
Scale (FSS)27 
Adult self-report Within last week 1 total score (9 
items) + global 
fatigue VAS 
Fatigue severity 1  W 7 rating scale 1  W 63 (raw) USA Yes 
Generalized 
Anxiety Disorder 
Scale 7-item (GAD-
7)39 
Adult self-report 2 weeks 1 total score (7 
items) 
Anxiety 0  W 3 rating scale 0  W 21 (raw) USA Yes 
Health Utilities 
Index 
Questionnaire mark 
2 (HUI-2) 15Q40-41 
Child self-report  
Adult self-report 
Proxy report 
During past 4 weeks 7 (15 items) Sensation; mobility; emotion; 
cognition; self-care; pain; fertility 
Varies by dimension AL0.03  W 1 
(utility scores) 
Canada Yes 
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Health Utilities 
Index 
Questionnaire mark 
3 (HUI-3) 15Q40-41 
Child self-report 
Adult self-report 
Proxy report  
During past 4 weeks 8 (15 items) Vision; hearing; speech; ambulation; 
dexterity; emotion; cognition; pain 
Varies by dimension AL0.36  W 1 
(utility scores) 
 
Canada Yes 
Hospital Anxiety 
and Depression 
Scale (HADS)27,38 
Adult self-report Last week 2 (14 items) Anxiety; depression 0  W 3 rating scale No total score 
calculated 
UK Yes 
Individualized 
Neuromuscular 
Quality of Life 
Questionnaire 
(INQOL)29 
Adult self-report At the moment 10 + a total score 
(45 items) 
Weakness; locking; pain; fatigue; 
activities; independence; social 
relationships; emotions; body image; 
treatment; total 
7-point rating scale, 
varies by dimension 
Scoring unclear UK Yes 
KIDSCREEN-1042 Child self-report 
Proxy report 
Last week 1 total score (10 
items) 
Health-related quality of life 1  W 5 rating scale  10  W 50 (raw)  Multi-country Yes 
KIDSCREEN-2743 Child self-report 
Proxy report 
Last week 5 (27 items) Physical well-being; psychological 
well-being; autonomy and parent 
relation; social support and peers; 
school environment 
1  W 5 rating scale No total score 
calculated 
Multi-country Yes 
KIDSCREEN-5244 Child self-report 
Proxy report 
Last week 10 (52 items) Physical well-being; psychological 
well-being; moods and emotions; 
self-perception; autonomy; parent 
relation and home life; financial 
resources; social support and peers; 
school environment; social 
acceptance (bullying) 
1  W 5 rating scale No total score 
calculated 
Multi-country Yes 
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Life Satisfaction 
Index for 
Adolescents 
(LSIA)45-48 
Child and young 
adults self-report 
At present 5 + a total score (45 
items) 
General well-being; interpersonal 
relationships; personal development; 
personal fulfilment; leisure and 
recreation; total 
1  W 5 rating scale 
(plus 0 = N/A) 
0  W 225 (raw) Canada Yes 
Muscular 
Dystrophy Child 
Health Index of Life 
with Disabilities 
(MDCHILD)49 
Child self-report Past 4 weeks 7 + a total score (47 
items) 
Activities of daily living & 
independence; positioning, 
transferring, & mobility; comfort & 
endurance; emotions & behaviour; 
social interaction & school; health; 
your overall quality of life; total   
Varies by dimension 0  W 100 
(transformed) 
Canada Yes 
Neurological 
Disorders Quality of 
Life Questionnaire 
(Neuro-QoL)26  
Adult self-report Varies by dimension Up to 16 (up to 564 
items in item 
banks) 
Ability to participate in social roles 
and activities; anxiety; bowel 
function; cognitive function; 
communication; depression; 
emotional and behavioral dyscontrol; 
fatigue; lower extremity function  W 
mobility; positive affect and well-
being; satisfaction with social roles 
and activities; sleep disturbance; 
sexual function; stigma; upper 
extremity function  W fine motor, ADL; 
urinary/bladder function  
1  W 5 rating scale No total score 
calculated 
USA Yes 
Offer Self-Image 
Questionnaire for 
Adolescents 
(OSIQ)45,48 
Child and young 
adult self-report 
or interview 
Unknown/undefined 11 + a total score 
(130 items) 
Impulse control; emotional tone; 
body and self-image; social 
relationships; morals; vocational and 
educational goals; family 
relationships; mastery of the 
external world; psychopathology; 
superior adjustment; total 
1  W 6 rating scale  130  W 780 (raw) USA No 
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Patient Health 
Questionnaire 9-
item (PHQ-9)39 
Adult self-report 2 weeks 1 total score (9 
items) 
Depression 0  W 3 rating scale 0  W 27 (raw) USA Yes 
Pediatric 
Neurological 
Disorders Quality of 
Life Questionnaire 
(Pediatric Neuro-
QoL)26 
Child self-report Varies by dimension Up to 11 (up to 161 
items in item 
banks) 
Anger; anxiety; cognitive function; 
depression; fatigue; lower extremity 
 W mobility; pain; social relations  W 
interaction with adults; social 
relations  W interaction with peers; 
stigma; upper extremity  W fine 
motor, ADL 
1  W 5 rating scale No total score 
calculated 
USA Yes 
Pediatric Outcomes 
Data Collection 
Instrument 
(PODCI)50-53 
Child self-report  
Proxy report 
Varies by dimension 7 (86 items) Global function & comfort; upper 
extremity function; physical function 
and sport; transfers and mobility; 
comfort; POSNA happy and satisfied; 
POSNA expectations  
Varies by dimension No total score 
calculated 
USA Yes 
Pediatric Quality of 
Life Inventory 
(PedsQL) 3.0 DMD 
module54-55 
Child and young 
adult self-report 
Proxy report 
Past month or past 7 
days (acute version) 
4 (18 items) Daily activities; treatment barriers; 
worry; communication 
0  W 4 rating scale No total score 
calculated 
USA Yes 
PedsQL 3.0 
Multidimensional 
fatigue scale 
(MFS)55-56 
Adult self-report 
Child and young 
adult self-report 
Proxy report 
Past month or past 7 
days (acute version) 
3 + a total score (18 
items) 
General fatigue; sleep/rest fatigue; 
cognitive fatigue; total fatigue 
0  W 4 rating scale  0  W 100 
(transformed) 
USA Yes 
PedsQL 3.0 
Neuromuscular 
module (NMM)26,41-
42,55-61 
Child and young 
adult self-report 
Proxy report  
Past month or past 7 
days (acute version) 
3 + a total score (25 
items) 
ďŽƵƚŵǇ ?ŵǇĐŚŝůĚ ?ƐŶĞƵƌŽŵƵƐĐƵůĂƌ
disease; communication; about our 
family resources; total 
0  W 4 rating scale 0  W 100 
(transformed) 
USA Yes 
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Pediatric Quality of 
Life Inventory 
(PedsQL) 4.0 
Generic Core Scales 
(GCS)26,34,42,50,53-
57,59,62-69 
Adult self-report 
Child and young 
adult self-report 
Proxy report 
Past month or past 7 
days (acute version) 
5 + a total score (23 
items) 
Physical health; psychosocial health; 
emotional functioning; social 
functioning; school functioning; total 
0  W 4 rating scale 0  W 100 
(transformed) 
USA Yes 
PedsQL 4.0 Generic 
Short-form (SF-
15)70 
Adult self-report 
Child and young 
adult self-report 
Proxy report 
Past month or past 7 
days (acute version) 
5 + a total score (15 
items) 
Physical health; psychosocial health; 
emotional functioning; social 
functioning; school functioning; total 
0  W 4 rating scale 0  W 100 
(transformed) 
USA Yes 
Pittsburgh Sleep 
Quality Index 
(PSQI)26,66 
Adult self-report Past month 8 + a total score (10 
items) 
Subjective sleep quality; sleep 
latency; sleep duration; sleep 
efficiency; sleep disturbance; use of 
sleep medication; daytime 
dysfunction; total 
Varies by dimension 0  W 21 (raw) USA Yes 
Satisfaction with 
Life Scale 
(SWLS)39,45 
Adult self-report Undefined/present 
time 
1 total score (5 
items) 
Life satisfaction 1  W 7 rating scale 5  W 35 (raw) USA Yes 
Strength and 
Difficulties 
Questionnaire 
(SDQ)71-73 
Child self-report 
Proxy report 
Last 6 months 5 + a total score (25 
items) + an impact 
supplement 
Emotional symptoms; conduct 
problems; hyperactivity/inattention; 
peer relationship problems; total 
difficulties; prosocial behaviour 
0  W 2 rating scale 0  W 40 (raw) UK Yes 
Strips of Life with 
Emoticons 
Questionnaire 
(SOLE)74 
Child self-report Specific scenarios 1 total score (33 
items) 
Quality of life 0  W 2 rating scale 
(with pictures) 
0  W 66 (raw) Italy No 
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TNO-AZL Children's 
Quality of Life 
questionnaire 
(TACQoL)75 
Child self-report  
Proxy report 
The last few weeks 7 (56 items) Physical functioning; motor 
functioning; independent daily 
functioning; cognitive functioning 
and school performance; social 
contacts; positive moods; negative 
moods 
Varies by dimension No total score 
calculated 
Netherlands No 
TNO-AZL 
Adult Quality of Life 
questionnaire 
(TAAQoL)75 
Adult self-report In the last month 12 (45 items) Gross motor functioning; fine motor 
functioning; cognition; sleep; pain; 
social contacts; daily activities; sex; 
vitality; happiness; depressive mood; 
anger 
Varies by dimension No total score 
calculated 
Netherlands No 
World Health 
Organisation 
Quality of Life 
Scale-Brief Version 
(WHOQOL-
BREF)24,26-28 
Adult self-report 
or interview  
Proxy report 
2 weeks 4 (26 items, 24 
items make up 
domain scores) 
Physical health; psychological; social 
relationships; environment 
1  W 5 rating scale No total score 
calculated 
Multi-country Yes 
Note.  References next to PROM names represent published studies where the PROM has been used in a sample of people with DMD.  
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A total of 40 PROMs used to assess at least one aspect of QoL in DMD were identified in published 
research articles through database searching (the two HUI classification systems use the same 15-item 
PROM). The majority of the PROMs were multidimensional (n = 32), designed to assess a range of 
different facets of QoL. The remaining unidimensional scales were designed to assess: activity 
limitations (CALI); anxiety (GAD-7); depression (BDI, DIKJ, PHQ-9); fatigue severity (FSS); life 
satisfaction (SWLS); or quality of life/health-related quality of life unidimensionally (KIDSCREEN, 
SOLE). Twenty-four of the PROMs had versions designed for completion by adult or young adult 
respondents, and 26 had versions designed for children. The most popular PROMs used in published 
research articles assessing QoL in people with DMD were the PedsQL 4.0 GCS (18 articles); PedsQL 3.0 
NMM (10 articles); and the SF-36 (8 articles).         
 
In the current review, 26 PROMs were taken forward for COSMIN quality assessment on content and 
structural validity in DMD. The remaining 14 PROMs were not assessed for the following reasons: a 
copy of the PROM itself and/or necessary development papers were not freely accessible for review 
(CAPE, CHQ-PF50, DISABKIDS Smileys, OSIQ, SF-36 v2); no formally validated English copy of the PROM 
was available or in use (AUQEI, DIKJ, DUC-25, SOLE, TAAQoL, TACQoL); the PROM was no longer 
available or recommended for use (BASC 1st edition, which has been superseded by the BASC 2); or it 
was unclear from the study which of a large number of possible variants of a PROM were used 
(pediatric Neuro-QoL, Neuro-QoL). Table 5 lists the PROMs taken forward for review.  
 
4.3 Content validity 
  
4.3.1 Appraisal of PROM development studies 
Table 5 summarises key characteristics and COSMIN quality assessment of the development of the 
PROMs included in the review, this includes the definition of the construct intended to be measured, 
target population, and intended context of use of the PROM. Five PROMs were developed to be 
intended for use specifically within neuromuscular disorders (INQoL, PedsQL 3.0 NMM) or DMD (LSIA, 
MDCHILD, PedsQL 3.0 DMD module; Table 5). Eleven PROMs either had no patients involved in their 
development, or it was unclear if patients were involved.  
 
The joint most common COSMIN quality rating assigned to the PROMs for concept elicitation was 
inadequate (n = 12). This was primarily due to: the PROM development study not being performed in 
a sample of patients representing the target population (BDI, EQ-5D-3L, GAD-7, HADS, HUI 15Q, 
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PedsQL 3.0 MFS, PHQ-9, SDQ, SF-36, and SWLS); or inadequacies within the details of the qualitative 
methods used (FSS, INQoL). The concept elicitation study of 11 further PROMs was rated as doubtful 
due to at least some unclear details/suspected problems within the qualitative methods used (CALI, 
DCGM-37, LSIA, MDCHILD, PODCI, PedsQL 3.0 NMM, PedsQL 3.0 DMD, PedsQL 4.0 GCS, PedsQL 4.0 
SF-15, PSQI, WHOQOL-BREF). Only the KIDSCREEN family of measures (n = 3) received an adequate 
rating for concept elicitation and PROM design. However, the KIDSCREEN measures received a 
doubtful rating for the overall PROM development study, for failing to provide evidence that 
comprehensibility and comprehensiveness were assessed in the cognitive interview/pilot study of the 
PROM. 
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Table 5.  Characteristics and assessment of development papers for PROMs included in the review. 
PROM Reference(s) Original language Construct definition Target population Intended context of use 
Concept elicitation study 
COSMIN quality rating Were patients involved? 
BDI Beck et al. 196176 English (US) "the items were chosen on 
the basis of their 
relationship to the overt 
behavioral manifestations 
of depression and do not 
reflect any theory 
regarding the etiology or 
the underlying 
psychological processes in 
depression" 
Adult patients with 
suspected symptoms 
of depression 
Quantitative assessment 
of the intensity of 
depression in diagnostic 
and research settings 
 
Inadequate No 
 
CALI Palermo et al. 200477 
 
English (US) 
 
"functional impairment, 
defined as difficulty in 
performing age-
appropriate physical, 
mental, and social 
activities in daily life due 
to physical health status 
( Q) functional impairment 
ĚƵĞƚŽƉĂŝŶ ? Q )specific 
areas of functioning that 
are important to children 
and adolescents with 
recurrent and chronic 
pain" 
School-age children 
and adolescents with 
recurrent and chronic 
pain 
Research and clinical 
care 
 
Doubtful Yes 
 
DCGM-37 Petersen et al. 200578 
Ravens-Sieberer et al. 
200779 
English (UK)  “ĂŵƵůƚŝĚŝŵĞŶƐŝŽŶĂů
construct with social, 
physical, emotional, and 
ĨƵŶĐƚŝŽŶĂůĚŽŵĂŝŶƐ ? 
Children aged 4-7 
years and 8-16 years 
with chronic health 
conditions 
Clinical studies or 
surveys 
Doubtful Yes 
EQ-5D-3L* EuroQol Group 199080 
Brooks et al. 199681 
Multiple, including 
English (UK) 
 “,ĞĂůƚŚ-related quality of 
ůŝĨĞ ? 
 “>ĂƌŐĞ-scale surveys 
of the community and 
 ? Q )ĨŽƌuse in postal 
ƐƵƌǀĞǇƐ ? 
 “ŽŵƉůĞŵĞŶƚŽƚŚĞƌ
quality of life measures, 
collection of common 
data set for reference. 
Generate cross-national 
comparisons of health 
ƐƚĂƚĞǀĂůƵĂƚŝŽŶƐ ? ?
Inadequate No 
FSS Krupp et al. 198982 
 
English (US) 
 
"Fatigue" Patients with "clinical 
disorders" 
Clinical research studies 
and surveys 
Inadequate No 
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GAD-7 Spitzer et al. 200683 English (US)  “tĞĨŝƌƐƚƐĞůĞĐƚĞĚ
potential items for a brief 
GAD [Generalized Anxiety 
Disorder] scale  ? Q )that 
reflected all of the 
Diagnostic and Statistical 
Manual of Mental 
Disorders, Fourth Edition 
(DSM-IV) symptom criteria 
for GAD and  ? Q )on the 
basis of review of existing 
ĂŶǆŝĞƚǇƐĐĂůĞƐ ? ? 
General adult 
population 
Clinical practice and 
research 
Inadequate No 
HADS Zigmond & Snaith 198384 
 
English (UK) "depression subscale were 
largely based on the 
ĂŶŚĞĚŽŶŝĐƐƚĂƚĞ ? Q )
psychic manifestations of 
anxiety neurosis" 
Patients under 
investigation and 
treatment in medical 
and surgical 
departments in non-
psychiatric hospital 
departments 
Clinical/screening use 
within non-psychiatric 
hospital departments 
Inadequate No 
HUI-2 / HUI-3 
(15Q) 
Feeny et al. 199585 
Torrance et al. 199686 
English (US) "The HUI Mark II and Mark 
III systems are based on 
concepts of functional 
capacity rather than 
performance  ? Q )generic 
health profile measures 
that also permit the 
computation of a single 
summary score quantifying 
health-related quality of 
life" 
Originally survivors of 
childhood cancer 
(HUI-2), extended to 
adults  
Clinical evaluative and 
population health survey 
studies, in clinical trials, 
and cost-utility analyses 
Inadequate Unknown 
INQoL Vincent et al. 200787 English (UK) "The structure of INQoL 
was based on the ICIDH-2 
model of disease 
incorporating the concepts 
of Impairment, Activities, 
and Participation." 
Adults with 
neuromuscular 
disorders (16+ years) 
Clinical and research use Inadequate Yes 
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KIDSCREEN-52 Ravens-Sieberer et al. 
200188 
Ravens-Sieberer et al. 
200589 
Detmar et al. 200690 
 
 
Multiple, including 
English (UK) 
 “,ĞĂůƚŚ-related quality of 
life is described as a 
multidimensional 
construct covering 
physical, emotional, 
mental, social, and 
behavioral components of 
well-being and function as 
perceived by patients 
ĂŶĚ ?ŽƌŝŶĚŝǀŝĚƵĂůƐ ? Q )
agreement was reached 
that the questionnaire 
should aim to measure 
HRQOL as a generic 
construct in largely healthy 
children, thus more 
emphasis was given to the 
inclusion of psychosocial 
domains, and less to 
domains of physical 
functioning or symptoms 
ƐƵĐŚĂƐƉĂŝŶ ? ?
Healthy and 
chronically-ill children 
and adolescents 
between 8 and 18 
years 
Epidemiological and 
paediatric studies, 
clinical settings 
(healthcare system), and 
health services research 
Adequate Yes 
KIDSCREEN-27 Ravens-Sieberer et al. 
200691 
Assumed the same 
as KIDSCREEN-52 
Assumed the same as 
KIDSCREEN-52 
Assumed the same as 
KIDSCREEN-52 
Assumed the same as 
KIDSCREEN-52 
Adequate Yes 
KIDSCREEN-10 Ravens-Sieberer et al. 
200691 
Assumed the same 
as KIDSCREEN-52 
Assumed the same as 
KIDSCREEN-52 
Assumed the same as 
KIDSCREEN-52 
Assumed the same as 
KIDSCREEN-52 
Adequate Yes 
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LSIA Reid & Renwick 199445 English (US) "quality of life is to 
conceptualize it as a 
subjective phenomenon. 
Specifically, it is viewed in 
terms of the individual's 
feelings and evaluations of 
his or her life 
circumstances. Many 
researchers who study 
quality of life within this 
perspective emphasize the 
importance of measuring 
the individual's degree of 
life satisfaction. In other 
words, they are interested 
in how pleased an 
individual feels about 
particular aspects of his or 
her life" 
 “/ŶĚŝǀŝĚƵĂůƐďĞƚǁĞĞŶ
the ages of 12 and 19 
ǇĞĂƌƐǁŚŽŚĂǀĞD ? 
Research instrument 
and potentially useful as 
a clinical measure 
Doubtful Yes 
MDCHILD Propp, 201792 
Propp et al. 201949 
English (UK)  “,ĞĂůƚŚ-related priorities 
ĨŽƌĐŚŝůĚƌĞŶǁŝƚŚD ? Q) 
defined as concerns, 
desires, and expectations 
arising from the lived 
experience of that 
ĐŽŶĚŝƚŝŽŶ ? 
Children with DMD 
(assumed 5  W 18 
years) 
Cohort studies, clinical 
trials, and clinical 
decision-making 
Doubtful Yes 
PedsQL 3.0 DMD Uzark et al. 201254 English (US) "Health-related quality of 
life (QoL), a 
multidimensional 
construct that includes 
physical, psychological, 
and social functioning, has 
emerged as an important 
outcome in pediatric 
populations with chronic 
health conditions." 
Children with DMD 
from 2  W 18 years 
Assumed the same as 
PedsQL 4.0 GCS 
Doubtful Yes 
PedsQL 3.0 MFS Varni et al. 200293 English (US) "designed to measure 
child and parent 
perceptions of fatigue in 
pediatric patients" 
Assumed the same as 
PedsQL 4.0 GCS 
 “ŵĂǇďĞƵƚŝůŝǌĞĚĂƐ
outcome measures in 
pediatric cancer clinical 
trials, research, and 
clinical practice for 
,ZYK> ? 
Inadequate Yes 
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PedsQL 3.0 NMM Iannaccone et al. 200994 English (US) "HRQOL is a 
multidimensional 
construct, consisting at the 
minimum of physical, 
psychological (including 
emotional and cognitive), 
and social health 
dimensions delineated by 
the World Health 
Organization. HRQOL has 
emerged as the most 
appropriate term for 
quality of life dimensions 
that represent a patient's 
perceptions of the impact 
of an illness and its 
treatment on their own 
functioning and well-being 
and which are within the 
scope of healthcare 
services and medical 
products." 
Children and young 
people with 
neuromuscular 
disorders, in particular 
spinal muscular 
atrophy 
Assumed the same as 
PedsQL 4.0 GCS 
Doubtful Yes 
PedsQL 4.0 GCS Varni et al. 199995 English (US) "The PedsQL measures the 
patient's and the parent's 
perceptions of the 
patient's HRQOL, as 
defined in terms of the 
impact of disease and 
treatment on an 
individual's physical, 
psychological, and social 
functioning, and by 
disease/treatment-specific 
symptoms." 
Children aged 8  W 18 
across various 
pediatric chronic 
health conditions 
Epidemiological studies, 
clinical trials, and 
performance 
improvement studies 
Doubtful Yes 
PedsQL 4.0 SF-15 Varni et al. 199995 English (US) Assumed the same as 
PedsQL 4.0 GCS 
Assumed the same as 
PedsQL 4.0 GCS 
Assumed the same as 
PedsQL 4.0 GCS 
Doubtful Yes 
 36 | P a g e  
 
PHQ-9 Spitzer et al. 199996 
Kroenke et al. 200197 
English (US)  “ĞƉƌĞƐƐŝŽŶ ? Q )ƵƐŝŶŐ
diagnostic criteria from the 
Diagnostic and Statistical 
Manual of Mental 
Disorders, Revised Third 
Edition (DSM-III-R) and 
Diagnostic and Statistical 
Manual of Mental 
Disorders, Fourth Edition 
(DSM-/sͿ͘͟ 
General adult 
population 
Clinical practice and 
research 
Inadequate No 
PODCI Daltroy et al. 199898 English (US) "The POSNA outcomes 
instrument scales assess 
upper extremity function, 
transfers and mobility, 
physical function and 
sports, comfort (painfree), 
happiness and satisfaction, 
and expectations for 
treatment. A POSNA global 
scale combines the three 
function subscales and 
comfort." 
Children aged 2-18 
years with 
musculoskeletal 
disorders 
 
 “WĂƚŝĞŶƚ-based 
ŝŶƐƚƌƵŵĞŶƚ ? 
Doubtful Yes (assumed) 
PSQI 
 
Buysse et al. 198999 
 
English (US) 
 
"sleep quality is a readily 
accepted clinical construct, 
it represents a complex 
phenomenon that is 
difficult to define and 
measure objectively. 
 ‘^ůĞĞƉƋƵĂůŝƚǇ ? includes 
quantitative aspects of 
sleep, such as sleep 
duration, sleep latency, or 
number of arousals, as 
well as more purely 
subjective aspects, such as 
"depth" or "restfulness" of 
ƐůĞĞƉ ? 
Clinical/psychiatric 
populations 
 
Psychiatric clinical 
practice and research 
activities 
 
Doubtful No 
 
SDQ Goodman 1997100 English (UK) "young people's 
behaviours, emotions, and 
relationships" 
Children and young 
people (aged 4-16 
years) 
"to meet the needs of 
researchers, clinicians, 
and educationalists" 
Inadequate No 
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SF-36 v1.0* Ware & Sherbourne, 
1992101 
Hays et al. 1993102 
Jenkinson et al. 1999103 
Ware 2000104 
English (US)  “ “,ĞĂůƚŚ ? ?ĞŝŐŚƚĐŽŶĐĞƉƚƐ P
physical functioning, social 
and role functioning, 
mental health, general 
health perceptions, bodily 
ƉĂŝŶ ?ĂŶĚǀŝƚĂůŝƚǇ ? ? 
 “'ĞŶĞƌĂůƉŽƉƵůĂƚŝŽŶ
ĂŶĚƉĂƚŝĞŶƚƐ ? 
 “ůŝŶŝĐĂůƉƌĂĐƚŝĐĞĂŶĚ
research, healthy policy 
evaluations, and general 
ƉŽƉƵůĂƚŝŽŶƐƵƌǀĞǇƐ ? 
Inadequate No 
SWLS Diener et al. 1985105 
 
English (US) "Life satisfaction refers to 
a cognitive, judgmental 
process. Shin and Johnson 
(1978) define life 
satisfaction as "a global 
assessment of a person's 
quality of life according to 
his chosen criteria" (p. 
478)" 
Unclear Unclear Inadequate No 
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WHOQOL-BREF WHOQOL Group 1994106 
WHOQOL Group 1995107 
Skevington et al. 1997108 
WHOQOL Group 1998109 
Multiple, including 
English (UK) 
" It is a broad ranging 
concept incorporating, in a 
complex way, the person's 
physical health, 
psychological state, level 
of independence, social 
relationships, personal 
beliefs, and relationship to 
salient features of the 
enǀŝƌŽŶŵĞŶƚ ? Q )At 
minimum, quality of life 
includes the following 
dimensions: physical 
(individuals' perception of 
their physical state), 
psychological (individuals' 
perception of their 
cognitive and affective 
state) and social 
(individuals' perception of 
the interpersonal 
relationship relationships 
and social roles in their 
life). ( Q )The WHOQOL 
includes a spiritual 
dimension (the person's 
perception of 'meaning in 
life', or the overarching 
personal beliefs that 
structure and qualify 
experience)." 
 “assess the quality of 
life of chronic disease 
sufferers, informal 
caregivers of the sick 
and disabled, people 
living in high-stress 
conditions like 
refugees, and 'healthy' 
people ? 
"in routine clinical work, 
large scale 
epidemiological studies 
and in clinical trials" 
Doubtful Yes 
Note. *PROM development information obtained from prior COSMIN review110, not re-extracted or re-rated in this review, based on COSMIN guidance9 
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4.3.2 Appraisal of content validity studies  
Aside from development studies, only 2 published articles had independently assessed the content 
validity of the QoL PROMs in samples of people with DMD, and the details of these studies and their 
COSMIN quality assessment are described in Table 6. Neither of these studies were conducted in a UK 
context, and instead were cross-cultural validation studies. Hu et al. (2013)59 assessed the relevance, 
comprehensiveness, and comprehensibility of the PedsQL 3.0 NMM in Chinese children with DMD. 
Simon et al. (2017)47 assessed comprehensibility of the LSIA in Brazilian children with DMD, and 
comprehensiveness in professionals. However, both of these studies received ratings of doubtful due 
to at least some unclear details/suspected problems within the qualitative methods used. 
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Table 6.  Characteristics and assessment of content validity papers in DMD samples for PROMs included in the review. 
PROM Reference Language (Country) 
DMD sample characteristics COSMIN rating 
Results (synthesis) N Age (years, ±SD) % ambulatory Relevance Comprehensiveness Comprehensibility 
LSIA Simon et al. 201747 
Brazilian 
Portuguese (Brazil) 
43 11.4 ± 3.38 Not stated / Doubtful  Doubtful 
The level of comprehension 
reached via the final Probe 
technique was 97% for the 
parent version and 95% for 
the patient version, which is 
above the minimum of 85% 
required.  
PedsQL 
3.0 NMM 
Hu et al. 201359 Chinese (China) 56 7.54 ±  4.06 
37 children 
 “ĐŽƵůĚĐůŝŵď
ƐƚĂŝƌƐ ? 
Doubtful Doubtful Doubtful 
Cognitive debriefing was 
conducted with six children 
with DMD and their parents 
to confirm that the final 
Chinese version was 
understandable and 
acceptable. 
Note. / = content validity aspect not evaluated. 
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4.3.3 Evidence synthesis 
The evidence from the PROM development papers and content validity studies was combined with 
reviewer ratings of the PROMs to produce a synthesis of the available evidence using the 10 COSMIN 
criteria for good content validity.9 Most of the quality of the evidence was downgraded from High to 
Low or Very Low due to the assessment being based on development studies of doubtful or 
inadequate quality, respectively.9 Only the LSIA and the PedsQL 3.0 NMM had moderate supporting 
evidence, featuring independent content validity studies as well as development papers. The 
KIDSCREEN measures and the LSIA were the only PROMs to receive satisfactory results for all three 
dimensions of content validity: relevance; comprehensiveness; and comprehensibility, based on the 
evidence available. Full synthesised results are presented in Table 7.     
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Table 7. Evidence synthesis on the content and structural validity of PROMs used to assess QoL in people with DMD. 
 Content validity Structural Validity 
PROM Relevance Comprehensiveness Comprehensibility Quality of evidence Rating of results Quality of evidence 
BDI ± AL ± Very low ? ? 
CALI + AL ± Low ? ? 
DCGM-37 ± + + Low ? ? 
EQ-5D-3L + AL + Very low ? ? 
FSS ± AL ± Very low ? ? 
GAD-7 + AL + Very low ? ? 
HADS AL AL AL Very low ? ? 
HUI-2 / HUI-3 (15Q) AL AL AL Very low ? ? 
INQoL ± ± + Very low ? ? 
KIDSCREEN-52 + + + Low ? ? 
KIDSCREEN-27 + + + Low ? ? 
KIDSCREEN-10 + + + Low ? ? 
LSIA + + + Moderate ? ? 
MDCHILD ± + + Low ? ? 
PedsQL 3.0 DMD ± ? ± Very low ? ? 
PedsQL 3.0 MFS ± AL ± Very low ? ? 
PedsQL 3.0 NMM ± ? ± Moderate AL High 
PedsQL 4.0 GCS ± + ± Low ? Very low 
PedsQL 4.0 SF-15 ± + ± Low ? ? 
PHQ-9 + AL ± Very low ? ? 
PODCI ± + ± Very low ? ? 
PSQI ± AL ± Very low ? ? 
SDQ AL AL + Very low ? ? 
SF-36 v1.0 + + ± Very low ? ? 
SWLS AL AL ± Very low ? ? 
WHOQOL-BREF + + ± Very low ? ? 
Note.  + = satisfactory results; AL = unsatisfactory results; ± = inconsistent results; ? = indeterminate.   
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4.4 Structural validity 
    
4.4.1 Appraisal of structural validity studies 
Two studies had assessed the structural validity of the PROMs included in this review in samples of 
people with DMD (Table 8). Both of these were conducted using English versions of the PROMs and 
either in the UK or USA. Lim et al. (2014)64 assessed the structural validity of the PedsQL 4.0 GCS using 
an unspecified Rasch model in 63 boys with DMD. This study received a COSMIN quality rating of 
doubtful because it was doubtful that the sample size included in the analysis was adequate. Landfeldt 
et al. (2018)58 assessed the structural validity of the PedsQL 3.0 NMM using a Rasch partial-credit 
model (PCM) in 278 people with DMD. This study received a very good COSMIN quality rating for its 
methodological content. 
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Table 8. Characteristics, assessment, and results of structural validity papers in DMD samples for PROMs included in the review. 
PROM Reference 
Country 
(language) 
Patient characteristics 
COSMIN 
Quality Rating 
Analysis ʹ 
model Results (synthesis) 
N Age (yr, M 
±SD) 
% ambulatory 
 
PROM score 
PedsQL 4.0 GCS 
 
Lim et al. 
201464 
USA 
(English) 
63 boys with 
DMD (and up to 
50 parents, not 
necessarily 
matched) 
 
10.2 ± 2.5  
 
95.24 
 
Child: M = 64.5, SD = 15.3. 
 
Parent: M=56.2, SD=12.9. 
 
Doubtful Rasch (model 
not specified) 
Model misfit for items determined 
with infit > 1.4 and outfit > 2.0 
MnSq values and standardized 
scores > 2.0. All items fit in parent 
proxy-reports of physical health 
scale and child self-reports of 
psychosocial health scale. 2 out of 
8 items showed high infit statistics 
in child self-reports of the physical 
health scale (taking a bath or 
shower; doing chores around the 
house). In addition 2 out of 15 
items showed high infit for the 
parent proxy-reports of the 
psychosocial health scale (trouble 
sleeping; keep up with school 
work). 
PedsQL 3.0 
NMM 
 
Landfeldt et al. 
201858 
UK / USA 
(English) 
278 (95 UK) 
 
16 ± 7 40% not "full-
time wheelchair 
dependent" 
Not reported 
 
Very good Rasch PCM Eight items displayed inadequate 
Ĩŝƚ ?ʖ2: p > 0.01). Six items had fit 
ƌĞƐŝĚƵĂůƐA?AL ? ? ?ŽƌA? ? ? ? ? ?
significant at p < .05). Inadequate 
ŽǀĞƌĂůůĨŝƚ ?ʖ2  item-trait 
interaction: p = < .001). 
Disordered thresholds for 22 of 25 
items. Suboptimal targeting.  
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4.4.2 Evidence synthesis  
Of the 2 studies that assessed the structural validity of the PedsQL 4.0 GCS and PedsQL 3.0 NMM in 
people with DMD, neither provided satisfactory results (Table 7). First, the structural validity of the 
PedsQL 4.0 GCS in people with DMD received an indeterminate rating, as key details of the results 
from the Rasch model denoting good measurement properties were not reported. Due to the risk of 
bias assessment of Lim et al. (2014)64 the quality of the evidence supporting this indeterminate 
conclusion was rated as very low. Second, the structural validity of the PedsQL 3.0 NMM in people 
with DMD received an unsatisfactory rating, as the psychometric criteria for good measurement 
properties were not met. The favourable risk of bias assessment for Landfeldt et al. (2018)58 meant 
that the quality of evidence supporting this conclusion was graded as high. 
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4.5 Quality assurance of the review  
The quality of this review was self-assessed against a newly derived COSMIN checklist14, designed to 
evaluate the quality of systematic reviews of health-related PROMs.  The results are displayed in Table 
9.  In general, the review meets numerous quality indicators as defined by the COSMIN team, including 
the elements included in the research aim, search strategies, article selection, and assessment of 
measurement properties and quality.  In a couple of instances, criteria have been partly met.  For 
example, in this review all instruments were included where a validated English copy was freely 
available for review.  It is possible that additional instruments could have been included if licenses 
were paid for to access the relevant PROMs and development materials.  Second, citation tracking 
(i.e. reference checking) was conducted on the final set of articles eligible at Stage 2 of the searches 
(n = 41), but not on results eligible for inclusion at Stage 1. 
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Table 9. Quality assessment of this systematic review against COSMIN guidance. 
COSMIN criteria Review meets 
criteria 
Elements included in the research aim:  
Construct of interest + 
Population of interest + 
Type of measurement instrument of interest + 
Measurement properties of interest + 
All available instruments included ± 
Only instruments included that have at least some evidence of measurement properties + 
Search strategy described + 
No search terms or validated search filter used for:   
Measurement properties ʝ 
Type of instrument ʝ 
Number of databases searched: 5 
Search in at least 2 databases + 
MEDLINE/PubMed + 
EMBASE + 
Additional databases + 
Reference checking used ± 
No time limits used or good arguments for a time limit + 
No language restrictions used + 
Inclusion and exclusion criteria clearly described + 
Reasons for excluding articles reported + 
Abstract selection by at least 2 reviewers? + 
Full-text article selection by at least 2 reviewers? + 
Abstract and full-text article selection by at least 2 reviewers? + 
Methodological quality of studies assessed + 
Quality assessment of studies done by at least 2 reviewers + 
Data on measurement properties extracted by at least 2 reviewers + 
Quality of the instrument (measurement properties) assessed + 
Quality assessment of the instrument by at least 2 reviewers + 
Results from multiple studies on the same instrument somehow combined (e.g., best evidence 
synthesis or pooling) 
+ 
Data synthesis was performed:  
Per measurement property + 
Only for domains (reliability, validity, responsiveness)  
Only for the whole instrument  
Recommendation provided for the best instrument:  
One instrument is recommended per construct + 
More instruments are recommended per construct  
No recommendation for the best instrument  
Results for the measurement properties reported as raw data + 
Number of measurement properties reported 2 
Conflict of interest or funding source declared + 
One of the authors of the review is also the developer of one of the instruments evaluated in the 
review 
ʝ 
Note.  + = criterion met; AL = criterion not met; ± = criterion partly met   
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5 Discussion and conclusion 
 
In this systematic review, the published scientific evidence on the content and structural validity of 
PROMs used to measure at least one aspect of QoL in people with DMD was thoroughly evaluated. 
The overriding theme was one of sparse evidence. Many PROMs that are being used to assess aspects 
of QoL in people with DMD are being utilised without the accompanying good quality evidence that 
supports their validity for this task. Only five of the PROMs uncovered in this review were specifically 
designed for use in people with neuromuscular problems (three for DMD), and only two of these have 
had their content and/or structural validity independently assessed in this population (with the 
content validity studies involving translated versions). When the evidence is available, most of it is 
either of a low quality, featuring insufficient detail in the published articles to make thorough and 
comprehensive assessments of content and structural validity as demanded by COSMIN,13 leading to 
doubtful ratings. Indeed, one of the highest quality pieces of evidence reviewed in terms of reported 
methodology, Landfeldt et al. (2018)58, reported insufficient structural validity of the PedsQL 3.0 
Neuromuscular module (NMM) in DMD.   
 
The results from the review should not be viewed as surprising. Many of the PROMs identified are 
what could be deƐĐƌŝďĞĚĂƐ “ůĞŐĂĐǇ ?ŵĞĂƐƵƌĞƐ ?They were developed at a time when the science of 
construct and item generation was largely overlooked. The content of instruments was largely defined 
by clinical or expert opinion, with little explanation of what that entailed. The reporting of such stages 
in publications or questionnaire manuals was not commonplace. The transparency of reporting on the 
early stages of PROM development has only gained traction in the last decade or so. Whilst this is a 
positive step for researchers, clinicians and users alike, progress can be limited by journal restrictions 
on word count and remit. It is however possible for such legacy measures to be appropriately validated 
(or have their validity assessed) in properly designed studies assessing content or structural validity in 
modern samples of people with DMD. The problem observed in this review is that researchers are 
likely using such measures as a consequence of precedent or tradition, rather than a supportive 
evidence base. Thus the first recommendation from this review is for more research into the content 
and structural validity of QoL PROMs used in DMD, and, if the PROMs are found to be insufficient on 
these criteria, for additional PROM development in DMD samples.   
 
The limitations of sparse evidence notwithstanding, some PROMs performed better than others under 
COSMIN assessment. First, the KIDSCREEN instrument (all versions) does show some evidence of 
applicability given that it covers many aspects of QoL. The PROM development study for the 
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KIDSCREEN instrument was the only one rated as adequate, it was designed to assess QoL in children 
and adolescents with chronic illnesses, and the ratings for the content validity of the measure were 
positive (based on the available evidence ŝŶƚŚĞŵĞĂƐƵƌĞ ?ƐĚĞǀĞůŽƉŵĞŶƚ). However, it must also be 
borne in mind that there is little or no direct evidence to support the content or structural validity in 
DMD, specifically. The original KIDSCREEN instrument (52-item version) was designed to assess 
multiple aspects of QoL, namely: physical well-being; psychological well-being; moods and emotions; 
self-perception; autonomy; parent relation and home life; financial resources; social support and 
peers; school environment; and social acceptance (bullying), covering much of the CMQM 
framework.6 The conceptual framework of the instrument is thus intuitively applicable to the 
Duchenne community; however the measurement of impact may be limited due to the target age 
range of the PROM itself (8 - 18 years). While this is not uncommon (i.e. differences in measuring QoL 
from child to adulthood), there is some question of the applicability for the broader DMD population 
given the lower age target. While we would recommend this PROM, above all others tested in the 
review, for measuring QoL in children and adolescents with Duchenne, more research is needed to 
definitively support the use of KIDSCREEN (and its derivatives) within DMD. 
 
The second-best performing PROM in this review was the LSIA, which received a satisfactory score for 
relevance, comprehensiveness, and comprehensibility in terms of content validity, based on the 
ŝŶĨŽƌŵĂƚŝŽŶĂǀĂŝůĂďůĞĂŶĚƌĞǀŝĞǁĞƌƐ ?ƌĂƚŝŶŐƐŽĨƚŚĞWZKDŝƚƐĞůĨ. However, the development study for 
this paper lacked key details necessary in good PROM development, and thus was rated as doubtful. 
Furthermore, while the LSIA was one of few measures to feature a content validity study, it was a 
cross-cultural adaptation study of a Brazilian version of the measure, and the results of the formal 
assessment of this study were doubtful. Thus, the LSIA is possibly a good candidate for measuring QoL 
in DMD, but more evidence is needed. While the measure is comprehensive, it only comes in a 45-
item version, which is potentially quite burdensome. Furthermore, the measure is designed for use in 
children and young adults only, and may not generalise to adults with DMD. 
 
The most recent PROM developed specifically for use in children and adolescents with DMD was the 
MDCHILD. ůƚŚŽƵŐŚ ƚŚĞ WZKD ŝƐ ĚĞƐŝŐŶĞĚ ƚŽ ŵĞĂƐƵƌĞ  “ŚĞĂůƚŚ-ƌĞůĂƚĞĚ ƉƌŝŽƌŝƚŝĞƐ ? ?49 much of the 
content maps onto the CMQM framework6 and thus covers QoL. While the MDCHILD had many 
commendable strengths in PROM design, the overall rating of the PROM development, based on the 
COSMIN worst score counts system,17 was rated as doubtful due to lack of details reported in the 
development papers. For example, it was unclear if skilled interviewer(s) were used; to what degree 
data was coded independently; and to what degree, if at all, at least two researchers were involved in 
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the data analysis. This led to a low quality of evidence. Further, because the target population of 
interest was not clearly defined (i.e. age ranges were not specified), despite performing well in other 
areas, the PROM received an inconsistent rating for relevance. These results speak to the potential 
harshness of a worst score counts system advocated by COSMIN, which we discuss further below.  
Further, because the PROM is new, there is a lack of published content validity studies that may 
improve the quality of evidence for the MDCHILD going forward, such as that contained in Chapter 7 
of a non-peer-reviewed thesis,92 not eligible for inclusion in the current review.   
 
The PedsQL and associated modules were the most commonly used out of all the PROMs identified 
within the review. It should be noted that the development studies of the PedsQL were rated as 
doubtful. There was little evidence to support the content validity of the neuromuscular module of 
the PedsQL 3.0 (NMM). Furthermore, the psychometric properties of the NMM were not well 
supported by Landfeldt et al. (2018)58. The inclusion of PedsQL within clinical practice, cohort studies 
or pragmatic trials in DMD thus appears to be based upon precedent and common use, rather than 
published empirical evidence of suitability, based on content and structural validity. A notable 
advantage of the PedsQL (and its derivatives) is the young child (via proxy report), child (self and proxy 
report), young adult forms (self-report), and adult forms, which have now been developed. A further 
consideration is that the PedsQL scales are designed to be used in parallel (e.g. the generic core scales 
with the NMM or DMD modules), but were assessed individually under COSMIN guidance. Thus 
comprehensiveness may be improved by using these scales together.  Nevertheless, in the absence of 
further evidence, it is difficult to recommend the routine use of the PedsQL to assess QoL in people 
with DMD on content and structural grounds. Instead, the findings of this review support the need for 
further PROM devĞůŽƉŵĞŶƚ ?ǁŚŝĐŚŝƐĂďůĞƚŽĂĐĐƵƌĂƚĞůǇĂƐƐĞƐƐƚŚĞŝŵƉĂĐƚŽĨDƵƉŽŶƉĞŽƉůĞ ?ƐYŽ> ?      
 
The search identified some PROM instruments that we were unable to obtain. Access to the PROM 
and/or associated development papers was limited due to licensing requirements, and therefore it 
was not possible to include these instruments within the review. It is unlikely that these instruments 
are commonly used within research and/or clinical practice due to the difficulties around access. Their 
suitability for the DMD population cannot formally be determined; however, their use is likely to be 
limited by a lack of accessibility derived from license restrictions, reflected in the few citations in which 
they appeared. 
 
Another consideration relevant to the selection of QoL PROMs for use in the DMD population is 
whether the PROM has accompanying utility weights to make it preference-based and amenable to 
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use in economic valuation. Most of the PROMs assessed in this review, except the EQ-5D-3L, HUI, and 
SF-36 (via the SF-6D)111 were not preference-based measures. Further, these preference-based 
measures did not perform well on assessments of content validity. However, alternative strategies are 
possible in order to obtain utility weights for some of the alternative PROMs discussed in this review, 
including our recommended PROM (KIDSCREEN) and the most widely-used PROM (PedsQL). These 
include mapping algorithms to a preference-based measure,112 enabling there use in cost-effective 
analysis. Nevertheless, these kinds of solutions are to a degree imperfect, and there is clearly room 
for the development of a new preference-based measure of QoL in people with DMD.    
 
This review adopted guidance developed by the COSMIN initiative, and has adhered to their 
recommended methods in identification of evidence, data extraction, data assessment and data 
synthesis. Whilst the appropriateness of these robust methods cannot be questioned, this has 
resulted in relatively low ratings of the PROMs included within the review. It is important to recognise 
that this does not suggest categorically that the instruments used within published and/or current 
studies are not appropriate or fit for purpose; content and structural validity only form one 
component of PROM suitability within a population. Furthermore, as stated, many of the instruments 
were developed at a time when instrument development methods and procedures were not reported 
 W that is not to say the development of the instruments is flawed, just that an assessment of them 
cannot be made. The COSMIN appraisal tools assume a worst score counts system for the rating of 
the methodological quality of studies.17 This means that, in theory, a study could be rated as very good 
or adequate on all but one criteria, on which it is rated as doubtful or inadequate, and the overall 
score is thus reduced to the latter lower-quality rating. Sometimes this can be because key details, 
such as whether skilled interviewers were used, are not reported. We thus think that there is room 
for constructive debate on the usefulness of retaining a worst score counts system, as opposed to an 
alternative procedure that better reflects the variance or range of ratings across the COSMIN criteria. 
An example of this could be to use numerical scores to represent ratings for each of the COSMIN 
criteria and to calculate a (weighted) total, within which ranges or bands of scores reflect sequential 
improvements in methodological quality, from inadequate to very good.     
 
Given that DMD is a rare condition, the development and validation of PROMs that measure the 
impact of the condition on QoL is challenging. The number of participants included within various 
phases of PROM development and validation will be lower than that of a condition such as diabetes, 
asthma or eczema. Some of the studies identified within the review included participants with other 
similar conditions. As part of the methods employed within the review, the inclusion criteria stated at 
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least 75% of the sample were to include men/boys with DMD. It is possible to expand the scope of the 
ƐĞĂƌĐŚƚŽŝŶĐůƵĚĞĂŵŽƌĞ “ƌĞůĂǆĞĚ ?criterion; however, it is not known how appropriate this would be.  
It can be postulated that other neuromuscular disorders could imply similar impacts upon QoL, 
however this has not been explored within the context of this review.   
 
The rarity of DMD also limits assessment of cross-cultural applicability of items, concepts and indeed 
the PROMs. Very little (or no) data was identified that explored this issue. Few studies reported on 
participant ethnicity, nor discussed any potential issues that may differ between different ethnic 
groups.  Some instruments were identified within the search that were not included within the review 
as no English version of the questionnaire was available or had been developed. Such instruments 
may be applicable to the DMD population, however this has yet to be determined and can only be 
assessed following a robust translational study.  
 
The focus of this review was to report on the content and structural validity of PROM instruments that 
have been used to quantify the impact of DMD on individual ?ƐYŽ> ?However, content and structural 
validity only address some aspects of PROM suitability, and further work could be undertaken to 
formally appraise the instruments described. Other measurement properties, such as psychometric 
performance, could be considered. Furthermore, the inclusion of subsidiary samples such as other 
neuromuscular disorders, may be of interest. One of the inclusion criteria of this review was a 75% 
DMD sample (as recommended within the COSMIN guidance), however given the rarity of DMD it may 
be appropriate to relax this approach to include a wider sample of neuromuscular disorders. 
 
This review is not without its limitations.  While the methodological approach of the review is robust 
and follows the recommendations of COSMIN and that of other published reviews, it must be 
acknowledged that the rating criteria of the PROMs identified can be viewed as harsh. The COSMIN 
approach encourages researchers and reviewers to critically appraise evidence of PROM development 
 W however the presence of evidence within published literature is sparse. That is not to say that the 
development phases did not occur, merely that they are not reported and/or not reported in sufficient 
detail as required by COSMIN assessment. dŽĐƌŝƚŝƋƵĞĂWZKD ?ƐĂƉƉůŝĐĂďŝlity using this criterion could 
be perceived as being unduly critical; more recent PROMs tend to report the early stages of instrument 
development, and we are assessing all PROMs by modern standards. Similarly, the descriptions of 
PROMs themselves are often lacking. Basic information such as number of items, recall period, domain 
structure and scoring procedure were noted to be sporadically reported, although better in recent 
literature. The COSMIN-recommended reviewer rating of the identified PROMs for suitability for DMD 
(as reported in Table 7) has a large subjective component. Whilst this was completed as per the 
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COSMIN guidelines (with two reviewers and discrepancies reconciled following discussion), some of 
the ratings are at risk of bias based on the team of raters. For example, it is not known whether similar 
ratings of suitability would be achieved if reviewed by an individual with DMD, a family member or 
carer of a person with DMD, or a clinician. This is further exacerbated when we consider what QoL is 
 W for the purpose of this review it was a multidimensional construct, PROMs that measure a subset of 
interest (such as depression) may be appropriate to include within studies as part of a host/suite of 
measures.  
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Appendix A: Full search strategies  
   
Embase Stage One 
  
1. Muscular Dystrophy/  
2. duchenne*.mp.  
3. 1 or 2  
4. (HR-PRO or HRPRO or HRQL or HRQoL or QL or QoL).ti,ab. or quality of life.mp. or (health index* 
or health indices or health profile*).ti,ab. or health status.mp. or ((patient or self or child or parent 
or carer or proxy) adj (appraisal* or appraised or report or reported or reporting or rated or 
rating* or based or assessed or assessment*)).ti,ab. or ((disability or function or functional or 
functions or subjective or utility or utilities or wellbeing or well being) adj2 (index or indices or 
instrument or instruments or measure or measures or questionnaire* or profile or profiles or scale 
or scales or score or scores or status or survey or surveys)).ti,ab. 
 
5. 'Pediatric Quality of Life Inventory'.mp.  
6. PedsQL.mp.  
7. (SF-36 or EQ-5D*).mp.  
8. "World Health Organization Quality of Life".mp.  
9. (KIDSCREEN or Pittsburgh Sleep Quality questionnaire or PSQI).mp. [mp=title, abstract, heading 
word, table of contents, key concepts, original title, tests & measures] 
 
10. "Childrens Assessment of Participation and Enjoyment".mp.  
11. (CAPE or "Child Health Questionnaire" or CHQ* or Health Utilities Index Questionnaire or 
HUI*).mp. 
 
12. (Fatigue Severity Scale or FSS or "Hospital Anxiety and Depression Scale" or HADS or COPE 
Inventory or "Quality of Life in Neuromuscular Disease").mp. 
 
13. (QoL-NMD DISABKIDS or "Depressionsiventar fur kinder und Jugendliche" or DIKJ or Beck 
Depression Inventory or BDI or CARE-NMD or State-Trait Anxiety Inventory or STAI or "Life 
Satisfaction Index for Adolescents" or LSI-A or Quality of Life Evaluation Scale or AUQUEI or Activity 
Limitations Questionnaire or ACTIVLIM).mp. 
 
14. (sf12 or sf 12 or short form 12 or shortform 12 or sf twelve or sftwelve or shortform twelve or 
short form twelve).mp. 
 
15. (sf36 or sf 36 or short form 36 or shortform 36 or sf thirtysix or sf thirty six or shortform 
thirtysix or shortform thirty six or short form thirtysix or short form thirty six).mp. 
 
16. 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15  
17. 4 or 16  
18. 3 and 17 
 
Embase Stage Two 
 
   
1. Duchenne muscular dystrophy/  
2. duchenne*.mp.  
3. 1 or 2  
4. Autoquestionnaire Qualite de vie Enfant Image.mp.  
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5. (Behavior Assessment System for Children or BASC or Parent Form 50 or PF50 or DUX-25 or 
EuroQoL 5-domain or Functional Independence Measure* or FIM).mp. 
 
6. (WeeFIM or Life Satisfaction Index or LSI or LSIA or Neurological Disorders Quality of Life 
Questionnaire or NeuroQOL or pediatric NeuroQOL or Offer Self-Image Questionnaire for 
Adolescents or OSIQ).mp. 
 
7. (Pediatric Outcomes Data Collection Instrument or PODCI or Neuromuscular module or DMD 
module or Multidimensional Fatigue Scale or Generic Short-Form or SF15).mp. 
 
8. (SDQ or 'Strips of Life with Emoticons Questionnaire' or SOLE or 'World Health Organisation 
Quality of Life Scale-Brief Version' or WHOQOL-BREF).mp. 
 
9. ('Strength and Difficulties Questionnaire').mp. [mp=title, abstract, heading word, drug trade 
name, original title, device manufacturer, drug manufacturer, device trade name, keyword, 
floating subheading word, candidate term word] 
 
10. "Individualized Neuromuscular Quality of Life Questionnaire".mp.  
11. (INQOL or Child Activity Limitations Interview or CALI or "Satisfaction with Life Scale" or 
SWLS).mp. 
 
12. 'Pediatric Quality of Life Inventory'.mp.  
13. ("Pediatric Orthopedic Society of North America Pediatric Musculoskeletal Functional Health 
Questionnaire" or POSNA or Pittsburgh Sleep Quality Index).mp. 
 
14. PedsQL.mp.  
15. (SF-36 or EQ-5D*).mp.  
16. "World Health Organization Quality of Life".mp.  
17. (KIDSCREEN or Pittsburgh Sleep Quality questionnaire or PSQI).mp. [mp=title, abstract, 
heading word, drug trade name, original title, device manufacturer, drug manufacturer, device 
trade name, keyword, floating subheading word, candidate term word] 
 
18. "Childrens Assessment of Participation and Enjoyment".mp.  
19. (CAPE or "Child Health Questionnaire" or CHQ* or Health Utilities Index Questionnaire or 
HUI*).mp. 
 
20. (Fatigue Severity Scale or FSS or "Hospital Anxiety and Depression Scale" or HADS or COPE 
Inventory or "Quality of Life in Neuromuscular Disease").mp. 
 
21. (QoL-NMD DISABKIDS or "Depressionsiventar fur kinder und Jugendliche" or DIKJ or Beck 
Depression Inventory or BDI or CARE-NMD or State-Trait Anxiety Inventory or STAI or "Life 
Satisfaction Index for Adolescents" or LSI-A or Quality of Life Evaluation Scale or AUQUEI or 
Activity Limitations Questionnaire or ACTIVLIM).mp. 
 
22. (sf12 or sf 12 or short form 12 or shortform 12 or sf twelve or sftwelve or shortform twelve or 
short form twelve).mp. 
 
23. (sf36 or sf 36 or short form 36 or shortform 36 or sf thirtysix or sf thirty six or shortform 
thirtysix or shortform thirty six or short form thirtysix or short form thirty six).mp. 
 
24. 12 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23  
------------------------------------------------------------- 
 
PsychINFO Stage One 
 
1. Muscular Dystrophy/  
2. duchenne*.mp.  
3. 1 or 2  
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4. (HR-PRO or HRPRO or HRQL or HRQoL or QL or QoL).ti,ab. or quality of life.mp. or (health 
index* or health indices or health profile*).ti,ab. or health status.mp. or ((patient or self or child 
or parent or carer or proxy) adj (appraisal* or appraised or report or reported or reporting or 
rated or rating* or based or assessed or assessment*)).ti,ab. or ((disability or function or 
functional or functions or subjective or utility or utilities or wellbeing or well being) adj2 (index or 
indices or instrument or instruments or measure or measures or questionnaire* or profile or 
profiles or scale or scales or score or scores or status or survey or surveys)).ti,ab. 
 
5. 'Pediatric Quality of Life Inventory'.mp.  
6. PedsQL.mp.  
7. (SF-36 or EQ-5D*).mp.  
8. "World Health Organization Quality of Life".mp.  
9. (KIDSCREEN or Pittsburgh Sleep Quality questionnaire or PSQI).mp. [mp=title, abstract, 
heading word, table of contents, key concepts, original title, tests & measures] 
 
10. "Childrens Assessment of Participation and Enjoyment".mp.  
11. (CAPE or "Child Health Questionnaire" or CHQ* or Health Utilities Index Questionnaire or 
HUI*).mp. 
 
12. (Fatigue Severity Scale or FSS or "Hospital Anxiety and Depression Scale" or HADS or COPE 
Inventory or "Quality of Life in Neuromuscular Disease").mp. 
 
13. (QoL-NMD DISABKIDS or "Depressionsiventar fur kinder und Jugendliche" or DIKJ or Beck 
Depression Inventory or BDI or CARE-NMD or State-Trait Anxiety Inventory or STAI or "Life 
Satisfaction Index for Adolescents" or LSI-A or Quality of Life Evaluation Scale or AUQUEI or 
Activity Limitations Questionnaire or ACTIVLIM).mp. 
 
14. (sf12 or sf 12 or short form 12 or shortform 12 or sf twelve or sftwelve or shortform twelve or 
short form twelve).mp. 
 
15. (sf36 or sf 36 or short form 36 or shortform 36 or sf thirtysix or sf thirty six or shortform 
thirtysix or shortform thirty six or short form thirtysix or short form thirty six).mp. 
 
16. 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15  
17. 4 or 16  
18. 3 and 17  
 
 
PsycINFO Stage Two 
1. Muscular Dystrophy/  
2. duchenne*.mp.  
3. 1 or 2  
4. Autoquestionnaire Qualite de vie Enfant Image.mp.  
5. (Behavior Assessment System for Children or BASC or Parent Form 50 or PF50 or DUX-25 or 
EuroQoL 5-domain or Functional Independence Measure* or FIM).mp. 
 
6. (WeeFIM or Life Satisfaction Index or LSI or LSIA or Neurological Disorders Quality of Life 
Questionnaire or NeuroQOL or pediatric NeuroQOL or Offer Self-Image Questionnaire for 
Adolescents or OSIQ).mp. 
 
7. (Pediatric Outcomes Data Collection Instrument or PODCI or Neuromuscular module or DMD 
module or Multidimensional Fatigue Scale or Generic Short-Form or SF15).mp. 
 
8. (SDQ or 'Strips of Life with Emoticons Questionnaire' or SOLE or 'World Health Organisation 
Quality of Life Scale-Brief Version' or WHOQOL-BREF).mp. 
 
9. ('Strength and Difficulties Questionnaire').mp. [mp=title, abstract, heading word, table of 
contents, key concepts, original title, tests & measures] 
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10. "Individualized Neuromuscular Quality of Life Questionnaire".mp.  
11. (INQOL or Child Activity Limitations Interview or CALI or "Satisfaction with Life Scale" or 
SWLS).mp. 
 
12. 'Pediatric Quality of Life Inventory'.mp.  
13. ("Pediatric Orthopedic Society of North America Pediatric Musculoskeletal Functional Health 
Questionnaire" or POSNA or Pittsburgh Sleep Quality Index).mp. 
 
14. PedsQL.mp.  
15. (SF-36 or EQ-5D*).mp.  
16. "World Health Organization Quality of Life".mp.  
17. (KIDSCREEN or Pittsburgh Sleep Quality questionnaire or PSQI).mp. [mp=title, abstract, heading 
word, table of contents, key concepts, original title, tests & measures] 
 
18. "Childrens Assessment of Participation and Enjoyment".mp.  
19. (CAPE or "Child Health Questionnaire" or CHQ* or Health Utilities Index Questionnaire or 
HUI*).mp. 
 
20. (Fatigue Severity Scale or FSS or "Hospital Anxiety and Depression Scale" or HADS or COPE 
Inventory or "Quality of Life in Neuromuscular Disease").mp. 
 
21. (QoL-NMD DISABKIDS or "Depressionsiventar fur kinder und Jugendliche" or DIKJ or Beck 
Depression Inventory or BDI or CARE-NMD or State-Trait Anxiety Inventory or STAI or "Life 
Satisfaction Index for Adolescents" or LSI-A or Quality of Life Evaluation Scale or AUQUEI or Activity 
Limitations Questionnaire or ACTIVLIM).mp. 
 
22. (sf12 or sf 12 or short form 12 or shortform 12 or sf twelve or sftwelve or shortform twelve or 
short form twelve).mp. 
 
23. (sf36 or sf 36 or short form 36 or shortform 36 or sf thirtysix or sf thirty six or shortform 
thirtysix or shortform thirty six or short form thirtysix or short form thirty six).mp. 
 
 
Cochrane Library Stage One 
Search Name: Duchenne for PP 
Last Saved: 11/04/2018 09:19:13 
Comment:  
 
ID Search 
#1 MeSH descriptor: [Muscular Dystrophy, Duchenne] explode all trees 
#2 duchenne*:ti,ab,kw 
#3 #1 or #2 
#4 (HR-PRO or HRPRO or HRQL or HRQoL or QL or QoL):ti,ab 
#5 (quality of life):ti,ab,kw 
#6 (health index* or health indices or health profile*):ti,ab,kw 
#7 (health status):ti,ab,kw 
#8 ((patient or self or child or parent or carer or proxy) near (appraisal* or appraised or report 
or reported or reporting or rated or rating* or based or assessed or assessment*)):ti,ab 
#9 ((disability or function or functional or functions or subjective or utility or utilities or 
wellbeing or well being) near/2 (index or indices or instrument or instruments or measure or 
measures or questionnaire* or profile or profiles or scale or scales or score or scores or status or 
survey or surveys)) .ti,ab 
#10 #4 or #5 or #6 or #7 or #8 or #9 
#11 ("Pediatric Quality of Life Inventory" or PedsQL or SF-36 or EQ-5D* or "World Health 
Organization Quality of Life" or WHOQoL or KIDSCREEN or Pittsburgh Sleep Quality questionnaire or 
PSQI or "Children's Assessment of Participation and Enjoyment" or CAPE or "Child Health 
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Questionnaire" or CHQ* or Health Utilities Index Questionnaire or HUI* or Fatigue Severity Scale or 
FSS or "Hospital Anxiety and Depression Scale" or HADS or COPE Inventory or "Quality of Life in 
Neuromuscular Disease" or QoL-NMD DISABKIDS or "Depressionsiventar fur kinder und Jugendliche" 
or DIKJ or Beck Depression Inventory or BDI or CARE-NMD or State-Trait Anxiety Inventory or STAI or 
"Life Satisfaction Index for Adolescents" or LSI-A or Quality of Life Evaluation Scale or AUQUEI or 
Activity Limitations Questionnaire or ACTIVLIM):ti,ab,kw 
#12 (sf12 or sf 12 or short form 12 or shortform 12 or sf twelve or sftwelve or shortform twelve 
or short form twelve):ti,ab,kw 
#13 (sf36 or sf 36 or short form 36 or shortform 36 or sf thirtysix or sf thirty six or shortform 
thirtysix or shortform thirty six or short form thirtysix or short form thirty six):ti,ab,kw 
#14 #11 or #12 or #13 
#15 #10 or #14 
#16 #3 and #15 
 
Cochrane Library Stage Two 
Search Name: Duchenne Stage Two for PP September 2018 
Last Saved: 18/09/2018 15:23:27 
Comment:  
 
ID Search 
#1 MeSH descriptor: [Muscular Dystrophy, Duchenne] this term only 
#2 (duchenne*):ti,ab,kw 
#3 #1 or #2 
#4 (Autoquestionnaire Qualite de vie Enfant Image):ti,ab,kw 
#5 ("Behavior Assessment System for Children" ):ti,ab,kw 
#6 (BASC):ti,ab,kw 
#7 (Parent Form 50):ti,ab,kw 
#8 (PF50 or DUX-25):ti,ab,kw 
#9 ("EuroQoL 5-domain"):ti,ab,kw 
#10 (Functional Independence Measure* or FIM):ti,kw,ab 
#11 (WeeFIM or Life Satisfaction Index or LSI or LSIA or Neurological Disorders Quality of Life 
Questionnaire or NeuroQOL or pediatric NeuroQOL or Offer Self-Image Questionnaire for 
Adolescents or OSIQ):ti,ab,kw 
#12 (Pediatric Outcomes Data Collection Instrument or PODCI or Neuromuscular module or DMD 
module or Multidimensional Fatigue Scale or Generic Short-Form or SF15):ti,ab,kw 
#13 (SDQ or 'Strips of Life with Emoticons Questionnaire' or SOLE or 'World Health Organisation 
Quality of Life Scale-Brief Version' or WHOQOL-BREF):ti,ab,kw 
#14 ('Strength and Difficulties Questionnaire'):ti,ab,kw 
#15 ("Individualized Neuromuscular Quality of Life Questionnaire"):ti,ab,kw 
#16 (INQOL or Child Activity Limitations Interview or CALI or "Satisfaction with Life Scale" or 
SWLS):ti,ab,kw 
#17 ('Pediatric Quality of Life Inventory'):ti,ab,kw 
#18 ("Pediatric Orthopedic Society of North America Pediatric Musculoskeletal Functional Health 
Questionnaire" or POSNA or Pittsburgh Sleep Quality Index):ti,ab,kw 
#19 (PedsQL):ti,ab,kw 
#20 (SF-36 or EQ-5D*):ti,ab,kw 
#21 ("World Health Organization Quality of Life"):ti,ab,kw 
#22 (KIDSCREEN or Pittsburgh Sleep Quality questionnaire or PSQI):ti,ab,kw 
#23 ("Childrens Assessment of Participation and Enjoyment"):ti,ab,kw 
#24 (CAPE or "Child Health Questionnaire" or CHQ* or Health Utilities Index Questionnaire or 
HUI*):ti,ab,kw 
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#25 (Fatigue Severity Scale or FSS or "Hospital Anxiety and Depression Scale" or HADS or COPE 
Inventory or "Quality of Life in Neuromuscular Disease"):ti,ab,kw 
#26 (QoL-NMD DISABKIDS or "Depressionsiventar fur kinder und Jugendliche" or DIKJ or Beck 
Depression Inventory or BDI or CARE-NMD or State-Trait Anxiety Inventory or STAI or "Life 
Satisfaction Index for Adolescents" or LSI-A or Quality of Life Evaluation Scale or AUQUEI or Activity 
Limitations Questionnaire or ACTIVLIM):ti,ab,kw 
#27 (sf12 or sf 12 or short form 12 or shortform 12 or sf twelve or sftwelve or shortform twelve 
or short form twelve):ti,ab,kw 
#28 (sf36 or sf 36 or short form 36 or shortform 36 or sf thirtysix or sf thirty six or shortform 
thirtysix or shortform thirty six or short form thirtysix or short form thirty six):ti,ab,kw 
#29 #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or 
#18 or #19 or #20 or #21 or #22 or #23 or #24 or #25 or #26 or #27 or #28 
#30 #3 and #29 
#31 "construct validity" or "content validity" or "criterion validity" or "inter rater reliability" or 
"interrater reliability" 
#32 #30 and #31 
------------------------------------------------------- 
CINAHL Stage One 
Search 
ID#  
Search Terms  Search Options  Last Run Via  Results  
S1  
(MH "Muscular 
Dystrophy, Duchenne")  
Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
Display  
S2  duchenne*  Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
Display  
S3  S1 OR S2  Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
Display  
S4  HR-PRO  Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Display  
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Advanced Search  
Database - CINAHL 
with Full Text  
S5  
((disability or function 
or functional or 
functions or subjective 
or utility or utilities or 
wellbeing or well being) 
N2 (index or indices or 
instrument or 
instruments or measure 
or measures or 
questionnaire* or 
profile or profiles or 
scale or scales or score 
or scores or status or 
survey or surveys))  
Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
Display  
S6  
HRPRO or HRQL or 
HRQoL  
Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
Display  
S7  
quality of life or health 
index* or health indices 
or health profile* or 
health status  
Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
Display  
S8  TI QL  Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
Display  
S9  TI QoL  Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
Display  
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S10  
((patient or self or child 
or parent or carer or 
proxy) and (appraisal* 
or appraised or report 
or reported or reporting 
or rated or rating* or 
based or assessed or 
assessment*))  
Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
Display  
S11  
S4 OR S5 OR S6 OR S7 
OR S8 OR S9 OR S10  
Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
Display  
S12  
(Pediatric Quality of Life 
Inventory or PedsQL or 
SF-36 or EQ-5D* or 
World Health 
Organization Quality of 
Life or WHOQoL or 
KIDSCREEN or 
Pittsburgh Sleep Quality 
questionnaire or PSQI 
or Childrens Assessment 
of Participation and 
Enjoyment or CAPE or 
Child Health 
Questionnaire or CHQ* 
or Health Utilities Index 
Questionnaire or HUI* 
or Fatigue Severity Scale 
or FSS or Hospital 
Anxiety and Depression 
Scale or HADS or COPE 
Inventory or Quality of 
Life in Neuromuscular 
Disease or QoL-NMD 
DISABKIDS or 
Depressionsiventar fur 
kinder und Jugendliche 
or DIKJ or Beck 
Depression Inventory or 
BDI or CARE-NMD or 
State-Trait Anxiety 
Inventory or STAI or Life 
Satisfaction Index for 
Adolescents or LSI-A or 
Quality of Life 
Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
Display  
 68 | P a g e  
 
Evaluation Scale or 
AUQUEI or Activity 
Limitations 
Questionnaire or 
ACTIVLIM)  
S13  
(sf12 or sf 12 or short 
form 12 or shortform 12 
or sf twelve or sftwelve 
or shortform twelve or 
short form twelve)  
Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
Display  
S14  
(sf36 or sf 36 or short 
form 36 or shortform 36 
or sf thirtysix or sf thirty 
six or shortform 
thirtysix or shortform 
thirty six or short form 
thirtysix or short form 
thirty six)  
Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
Display  
S15  S12 OR S13 OR S14  Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
Display  
S16  S11 OR S15  Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
Display  
S17  S3 AND S16  Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
754 
 
CINAHL Stage Two 
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Search 
ID#  
Search Terms  Search Options  Last Run Via  Results  
S1  
(MH "Muscular 
Dystrophy, Duchenne")  
Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
1,330  
S2  duchenne*  Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
1,800  
S3  S1 OR S2  Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
1,800  
S4  
Autoquestionnaire 
Qualite de vie Enfant 
Image  
Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
3  
S5  
(Behavior Assessment 
System for Children or 
BASC or Parent Form 50 
or PF50 or DUX-25 or 
EuroQoL 5-domain or 
Functional 
Independence 
Measure* or FIM)  
Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
3,288  
S6  
(WeeFIM or Life 
Satisfaction Index or LSI 
or LSIA or Neurological 
Disorders Quality of Life 
Questionnaire or 
NeuroQOL or pediatric 
Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
559  
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NeuroQOL or Offer Self-
Image Questionnaire for 
Adolescents or OSIQ)  
Database - CINAHL 
with Full Text  
S7  
(Pediatric Outcomes 
Data Collection 
Instrument or PODCI or 
Neuromuscular module 
or DMD module or 
Multidimensional 
Fatigue Scale or Generic 
Short-Form or SF15)  
Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
197  
S8  
(SDQ or 'Strips of Life 
with Emoticons 
Questionnaire' or SOLE 
or 'World Health 
Organisation Quality of 
Life Scale-Brief Version' 
or WHOQOL-BREF)  
Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
6,403  
S9  
('Strength and 
Difficulties 
Questionnaire')  
Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
948  
S10  
"Individualized 
Neuromuscular Quality 
of Life Questionnaire"  
Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
3  
S11  
(INQOL or Child Activity 
Limitations Interview or 
CALI or "Satisfaction 
with Life Scale" or 
SWLS)  
Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
837  
S12  
'Pediatric Quality of Life 
Inventory'  
Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
521  
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Advanced Search  
Database - CINAHL 
with Full Text  
S13  
("Pediatric Orthopedic 
Society of North 
America Pediatric 
Musculoskeletal 
Functional Health 
Questionnaire" or 
POSNA or Pittsburgh 
Sleep Quality Index)  
Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
1,548  
S14  PedsQL  Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
651  
S15  (SF-36 or EQ-5D*)  Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
16,749  
S16  
"World Health 
Organization Quality of 
Life"  
Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
623  
S17  
(KIDSCREEN or 
Pittsburgh Sleep Quality 
questionnaire or PSQI)  
Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
1,040  
S18  
"Childrens Assessment 
of Participation and 
Enjoyment"  
Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
0  
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Advanced Search  
Database - CINAHL 
with Full Text  
S19  
(CAPE or "Child Health 
Questionnaire" or CHQ* 
or Health Utilities Index 
Questionnaire or HUI*)  
Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
3,751  
S20  
(Fatigue Severity Scale 
or FSS or "Hospital 
Anxiety and Depression 
Scale" or HADS or COPE 
Inventory or "Quality of 
Life in Neuromuscular 
Disease")  
Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
530,689  
S21  
(QoL-NMD DISABKIDS 
or "Depressionsiventar 
fur kinder und 
Jugendliche" or DIKJ or 
Beck Depression 
Inventory or BDI or 
CARE-NMD or State-
Trait Anxiety Inventory 
or STAI or "Life 
Satisfaction Index for 
Adolescents" or LSI-A or 
Quality of Life 
Evaluation Scale or 
AUQUEI or Activity 
Limitations 
Questionnaire or 
ACTIVLIM)  
Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
9,541  
S22  
(sf12 or sf 12 or short 
form 12 or shortform 12 
or sf twelve or sftwelve 
or shortform twelve or 
short form twelve)  
Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
524  
S23  
(sf36 or sf 36 or short 
form 36 or shortform 36 
or sf thirtysix or sf thirty 
six or shortform 
thirtysix or shortform 
Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
2,253  
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thirty six or short form 
thirtysix or short form 
thirty six)  
Advanced Search  
Database - CINAHL 
with Full Text  
S24  
S4 OR S5 OR S6 OR S7 
OR S8 OR S9 OR S10 OR 
S11 OR S12 OR S13 OR 
S14 OR S15 OR S16 OR 
S17 OR S18 OR S19 OR 
S20 OR S21 OR S22 OR 
S23  
Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
561,269  
S25  S3 AND S24  Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
250  
S26  
TX "construct validity" 
or "content validity" or 
"criterion validity" or 
"inter rater reliability" 
or "interrater reliability"  
Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
55,290  
S27  S25 AND S26  Search modes - Boolean/Phrase    
Interface - 
EBSCOhost 
Research 
Databases  
Search Screen - 
Advanced Search  
Database - CINAHL 
with Full Text  
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